학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 70건 | 목록
1~20
Academic Journal
Builes Ramírez, Sergio ; Acea Nebril, Benigno; García Novoa, Alejandra; Cereijo, Carmen; Bouzón, Alberto; Mosquera Oses, Joaquín
In Cirugía Española (English Edition) April 2020 98(4):212-218
Academic Journal
Diabetes Therapy. November, 2023, Vol. 14 Issue 11, p1959, 18 p.
Academic Journal
In Cirugía Española (English Edition) August-September 2016 94(7):372-378
Academic Journal
García Novoa, Alejandra ; Acea Nebril, Benigno ; Díaz, Inma ; Builes Ramírez, Sergio ; Varela, Cristina ; Cereijo, Carmen ; Mosquera Oses, Joaquín ; López Calviño, Beatriz ; Seoane Pillado, María Teresa
In Cirugía Española (English Edition) June-July 2016 94(6):331-338
Academic Journal
Colorectal Disease. 21:851-851
Academic Journal
Abad, P.; Abreu, P.; Acencio, N.; Acevedo, S.; Acevedo, V.; Agohn, R.; Albornoz, L.; Alvarez, P.; Arana, C.; Arango, A.; Arango, J. J.; Arbeláez, A.; Arbeláez, L. E.; Arboleda, W.; Arenas, A.; Arenas, I. C.; Arias, M. L.; Aristizábal, A.; Aristizábal, D.; Arrieta, E.; Arrieta, M.; Arroyave, H.; Arroyo, J. A.; Arteaga, F.; Ascione, G.; Asenjo, R.; Astudillo, B.; Atehortúa, L. H.; Badel, A.; Badiel, M.; Balestrini, S.; Barragán, R.; Barrera, C.; Barrera, J. C.; Barrera, J. G.; Benítez, L. M.; Bermúdez, M. J.; Bernal, O.; Betancourt, J.; Blanco, G.; Bohórquez, R.; Bravo, D.; Bresciani, R.; Builes, A.; Buitrago, L; Burgoa, A.; Báez, L. P.; Cabrales, J.; Cabrales, M.; Cabrera, C.; Cadavid, A. M.; Cadavid, E.; Cadena, R.; Caicedo, L. C.; Caicedo, V.; Calderón, J.; Calderón, L. I.; Camacho, J.; Camacho, P.; Camacho, P. A.; Camargo, D. M.; Campos, M. T.; Campuzano, G.; Capasso, A.; Cardona, H.; Cardona, J.; Carreño, A.; Carreño, M.; Carrillo, G.; Casariego, G.; Cassalett, G.; Castellanos, H.; Castillo, M.; Castillo, V.; Castro, H.; Castro, J.; Castro, P.; Cañas, E.; Celis, A.; Celis, L. A.; Chávez, A.; Chávez, J. C.; Colorado, A.; Contreras, E.; Coral, A.; Coronado, M.; Correa, J. R.; Corredor, S.; Corzo, L.; Corzo, O.; Cotes, J. M.; Cruz, A.; Cubides, C.; Cuellar, F.; Cuervo, A.; Cárdenas, A.; Cárdenas, M.; Cárdenas, M. E.; Cárdenas, P. E.; Cárdenas, W.; De Viveros, C.; Delgadillo, A.; Delgado, J.; Delgado, P.; Donado, B. P.; Donado, J. R.; Duarte, E.; Dueñas, R.; Duque, J. G.; Duque, M.; Durango, L.; Durán, A. E.; Durán, M. A.; Dávila, L. M.; Díaz, A.; Díaz, A. L.; Díaz, C.; Díaz, G.; Díaz, L.; Díaz, L. A.; Díaz, L. H.; Díaz, M.; Díaz, S.; Díaz, V; Echavarría, J.; Echeverri, D.; Echeverri, M.; Echeverría, L.; Echeverría, R.; Erdmenger, J.; Escobar, A.; Escobar, C.; Escobar, E.; Escorcia, E.; Espinosa, A.; Espíndola, R.; Estrada, G.; Estrada, J.; Estupiñán, A. M.; Eusse, C.; Fernández, A.; Fernández, D.; Fernández, H.; Fernández, N.; Fernández, O.; Fernández, R.; Flórez, M.; Fontanilla, M. R.; Fragozo, C. A.; Franco, C.; Franco, G.; Franco, H. J.; Franco, J.; Franco, S.; Gallo, J.; Garcés, J.; García, E.; García, L.; Garzón, M. E.; Gaviria, A.; Gil, E.; Giraldo, D.; Giraldo, J. A.; Giraldo, JC.; Giraldo, N.; Gomesese, O. F.; González, G.; González, M.; González, R.; Gordillo, M.; Guanes, R.; Guerra, P.; Guerrero, L.; Guitérrez, L.; Gulh, F.; Gutiérrez, J.; Gutiérrez, M.; Guyatt, G.; Guzmán, L.; Guzmán, N.; Gárces, J.; Gómez, A.; Gómez, C. A.; Gómez, F.; Gómez, G.; Gómez, G. S.; Gómez, J.; Gómez, J. F.; Gómez, M.; Gómez, P. F.; Hernández, A.; Hernández, C.; Hernández, E.; Hernández, G.; Hernández, H.; Hernández, L.; Hernández, N.; Herrera, V. M.; Hoyos, A.; Hurtado, E. F.; Ibarra, P.; Indaburu, D.; Iragorri, A.; Isaza, D.; Jaimes, F.; Jaimes, G.; Jaramillo, C.; Jaramillo, C. J.; Jaramillo, G.; Jaramillo, J.; Jaramillo, J. C.; Jaramillo, J. S.; Jaramillo, M.; Jaramillo, M. H.; Jaramillo, N.; Jaramillo, R.; Jiménes, M.; Jiménez, C.; Jiménez, L.; Jiménez, L. S.; Jiménez, M.; Jurado, A.; Jurado, A. F.; Lemus, J.; Leyes, R.; León, J.; Lince, R.; Lizarazo, J.; Lizcano, F.; Llamas, A.; Llano, J. F.; Lombo, B.; Lozano, M.; Luengas, C.; Lugo, L. H.; López, F.; López, M.; López, P.; Malabet, I.; Maldonado, J.; Manrique, E. J.; Manrique, F.; Mantilla, G.; Manzi, E.; Martínez, H.; Martínez, J. P.; Martínez, L. X.; Martínez, M. P.; Marín, J.; Mateus, L.; Matías, N.; Mayorga, A.; Medina, A.; Medina, E.; Medina, H.; Mejía; Mejía, A.; Mejía, D.; Mejía, I.; Mendoza, S.; Merchán, A.; Merlano, S.; Miranda, A.; Molina, C.; Montenegro, J.; Montero, A.; Montero, G.; Montero, G. A.; Montes, F.; Montoya, E.; Montoya, J. D.; Montoya, L. M.; Montoya, M.; Moreno, E.; Morillo, C.; Morillo, C. A.; Morris, R.; Mosquera, W.; Moya, L.; Murgueitio, R.; Muñoz, A.; Mármol, J. A.; Márquez, A.; Múnera, A.; Nader, C.; Navas, C. M.; Navia, J. J.; Negrete, A.; Niño, M. E.; Náder, C. A.; Núñez, F.; Ochoa, J.; Olaya, C.; Olaya, L.; Orjuela, A.; Orjuela, H.; Orozco, J. L.; Orrego, C. M.; Ortiz, C.; Ortiz, S. D.; Osorio, E.; Ospina, C. A.; Oviedo, M.; Oñate, R.; Pabón, L. M.; Palomino, G.; Pardo, C.; Pardo, R.; Parra, G. A.; Parra, J. C.; Parra, L. E.; Parra, T.; Patarroyo, M.; Pava, L. F.; Pedraza, J. E.; Pedraza, O.; Peláz, A. M.; Perafán, A.; Perafán, P.; Perafán, S.; Petro, C.; Pineda, M.; Pinzón, J. B.; Pira, P. S.; Pizarro, C.; Piñeros, D.; Plata, R.; Portilla, P.; Prada, E.; Pradilla, G.; Pulgarín, L. G.; Páez, G.; Páez, L.; Pérez, C.; Pérez, G. E.; Pérez, J.; Pérez, M.; Quesada, K.; Quintero, A.; Quintero, D.; Quintero, M.; Quiroz, C.; Ramos, M. L.; Ramírez, A.; Ramírez, I.; Ramírez, L.; Ramírez, M.; Ramírez, O.; Ramírez, S.; Rangel, G. W.; Rendón, J. C.; Restrepo, A.; Restrepo, G.; Restrepo, J. A.; Reynolds, J.; Rincón, J. D.; Rincón, O. S.; Rincón, P.; Rivas, G.; Rivas, L. F.; Riveros, F.; Roa, J. L.; Roa, N.; Rodríguez, A.; Rodríguez, D. C.; Rodríguez, E.; Rodríguez, J.; Rojas, C. E.; Rojas, J. C.; Romero, M. F.; Rosas, F.; Rosas, J. F.; Rosso, F.; Rueda, C. L.; Rueda, M.; Rueda-Clausen, C. F.; Ruiz, A.; Ruiz, D.; Ruiz, E. J.; Ruiz, H.; Ruiz, M.; Ruz, M.; Saaibi, J. F.; Saaibi, L. C.; Salazar, C.; Salazar, D.; Salazar, G.; Saldarriaga, C.; Saldoval, N.; Sanabria, C. L.; Sandoval, A. G.; Sandoval, J. M.; Sandoval, N.; Sandoval, N. F.; Santos, H.; Sarmiento, J. M.; Satizábal, C.; Senior, J. M.; Serano, D.; Serrano, N. C.; Silva, F.; Silva, F. A.; Silva, S. Y.; Smieja, M.; Solano, E.; Solano, J. A.; Suárez, M.; Sáenz, L.; Tello, J.; Tenorio, C.; Tenorio, L. F.; Thabane, L.; Tique, C.; Toro, N.; Torres, A.; Torres, G.; Torres, P.; Torres, Y.; Trujillo, P.; Téllez, M. R.; Umaña, J.; Uribe, C. E.; Uribe, F.; Uribe, W.; Urrego, M. T.; Vacca, M.; Vallejo, M.; Vanegas, D.; Vanegas, D. I.; Vanegas, E.; Vargas, C.; Vargas, R. D.; Vega, J. A.; Velasco, H. M.; Velasco, V. M.; Velásquez, D.; Velásquez, J.; Velásquez, J. G.; Velásquez, M.; Velásquez, O.; Vesga, B. E.; Vesga, B.E.; Vidal, C.; Villa, L. A.; Villa, V.; Villa-Roel, C.; Villalba, J. C.; Villalobos, C.; Villamil, C.; Villamizar, C.; Villamizar, E.; Villar, J. C.; Villegas, A.; Villegas, F.; Villegas, F. A.; Villegas, M. F.; Vázquez, C.; Vélez, J. F.; Vélez, L. A.; Vélez, S.; Yabur, M.; Zapara, J.; Zapata, H.; Zapata, J.; Zarruk, J. G.; Zuluaga, A.; Zuluaga, O.
Revista Colombiana de Cardiología, Vol 12, Iss 5, Pp 179-274 (2006)
Revista Colombiana de Cardiología, Volume: 12, Issue: 5, Pages: 179-274, Published: JAN 2006
Revista Colombiana de Cardiología, Volume: 12, Issue: 5, Pages: 179-274, Published: JAN 2006
Book
Cárdenas-Flórez, Adrián Ricardo; Quinchía Figueroa, Adriana María; Tercjak, Agnieszka; Marrugo Quintero, Alejandra Isabel; Luna, Alejandra; López Córdoba, Alex; Leyton Coneo, Alexander de Jesús; García Pérez, Alexander; Cuellar Burgos, Alneira; Realpe Jiménez, Álvaro; Cabarcas Álvarez, Amaury; Bossio Sánchez, Amaury Rafael; Echavarría, Ana Paola; Franco Pérez, Ana Sofía; Sánchez-Camargo, Andrea; Campuzano, Andrés; Rojas González, Andrés Felipe; Camacho Contreras, Andrés Fernando; González Delgado, Ángel Darío; Villabona Ortiz, Ángel; Beltrán Osuna, Ángela A.; García Acero, Angela María; Vanegas, Ángela; Ruiz Rodríguez, Angélica María; Álvarez, Angely; Hormiga Hernández, Angie Lorena; Suárez Mejía, Angie Melissa; Palomares Gimeno, Antonio; Picado, Apolinar; Martínez, Armando; Martín Pinto, Bradly Alejandro; Sanabria, Camilo Andrés; Monroy-Peña, Camilo; Tejada Tovar, Candelaria; Camargo Vila, Carlos Alfredo; Coy Barrera, Carlos; Quintero, Carlos; de León, Carmen Matilde; Rangel, Carol; Mejía Liévano, Carolina; Molinares Jiménez, Carolina; Ariza-Quiroga, Caterine; Ortega Jurado, César Alejandro; Quiñones Segura, César Augusto; Sánchez Correa, César Augusto; Benedito Battistela, César; Fabricio Pacheco, César; Villavicencio Yanos, Christian; Iribarrem Benites, Cibelem; Santa Chalarca, Cristiam Fernando; Pedroso Yoshida, Cristiana Maria; Castro, Cristina; Borras, Daniel; Builes, Daniel H.; Marín, Daniel; Cañón Pineda, Daniel Steven; Ostos Novoa, Daniela Alejandra; Carmona, Daniela; Mainardi, Daniela Silvia; Jurado Erazo, Danya Katherine; Becerra Navas, Darío Eduardo; Peña- Ballesteros, Darío Yesid; Cubides, David; Otálora, David Santiago; Alcida Nabarlatz, Débora; Noriega Verdugo, Delia; Tusso Pinzón, Diana Carolina; Guzmán S., Diana K.; Cuesta Parra, Diana Marcela; Sánchez Rubio, Diani Carolina; Orrego Grisales, Diego Andrés; Rueda Baquero, Diego Andrés; Cifuentes Galindres, Diego Francisco; Quiroga, Diego; Carmona, Dora María; Abril Fonseca, Duvan; Vargas Solano, Édgar Mauricio; Torres, Édgar; Pulido Arias, Edna Lizeth; Sánchez, Eduardo; Coy Barrera, Ericsson; Rico Rodríguez, Fabian; Mendoza Villarraga, Fabio Andrés; López Duarte, Fabio; Chejne Janna, Farid; González, Federico; López Muñoz, Federico; Correa Mahecha, Felipe; Vargas Torres, Felipe; Viejo Abrante, Fernando; Canelo, Francisco; Yánez, Francisco; Ramos, Francisco; Avellaneda Vargas, Fredy Augusto; Bohórquez Vega, Gaydi; Talavera, Geniel; Riaño, George; Morocho, Geovanny; Gómez, Geraldyne; Rodríguez Niño, Gerardo; de Ávila, Gezira; Gauthier, Gilles Henri; Ramírez Caballero, Gustavo Emilio; Luna Wandurraga, Héctor Javier; Soto, Hesneider; Huamani Yupanqui, Hugo Alfredo; Salgado Escobar, Irma; Castellanos Cuellar, Isabel Cristina; Hernández, Isacc; Cabeza, Iván; Santiago Céspedes, Iván D.; Arturo Calvache, Jaime Eduardo; Perilla, Jairo E.; Arroyo León, Jaison Daniel; Cristancho Mora, Javier Stiven; Teherán, Jefferson Arturo; León Pulido, Jeffrey; Marín Cabra, Jessica Paola; Ruiz Duarte, Jheriany Camila; Mosquera, Jhessica; Aceros-Cabezas, Jhon Freddy; Valencia Arredondo, Jhonnyer Julián; Bravo Romaina, Joana Milagros; Martínez Triguero, Joaquín; Herrera, Johana; Orjuela, Johana; Convers Sánchez, José Daniel; Marín Batista, José Daniel; Marrugo Negrete, José Luis; Pereira Rodrigues, José Roberto; Sorrentino, José; Alonso, Juan; Méndez Cárdenas, Juan Ángel; Correa Caraballo, Juan Camilo; Burgos Beltrán, Juan Carlos; Orozco- Agamez, Juan Carlos; Serrato Bermúdez, Juan Carlos; Llano Vásquez, Juan David; Tabares Hurtado, Juan David; Aldana, Juan Felipe; Dacundo Cárdenas, Juan Francisco; González Amaya, Juan Francisco; García Méndez, Juan Miguel; Cortés, Juan Pablo; Restrepo, Juan; Moreno Corredor, Juan Sebastián; González de La Ossa, Julián Andrés; Otavia Bahú, Juliana; Puello Méndez, Juliana; Lara Díaz, Julieth Angélica; Vargas, Julio Cesar; Rocha Rodríguez, Karen Daniela; Ojeda, Karina; Salazar Rivera, Karol Ximena; Forero González, Katherinn Viviana; Martínez, Kenia; Gutiérrez, Kevin; Zuniga Linan, Lamia; Gaitán, Laura; Cañaveral González, Laura Liliana; Pacheco, Laura; Plazas Tovar, Laura; Pramparo, Laura; Cuervo, Laura Viviana; Pernett, Leda; Pinchao Cuatin, Leidy Maribel; León, Leinis; Rojas Pérez, Lilia Carolina; Flórez, Liliana Katerin; Castañeda, Lina Marcela; Abril Moreno, Lina María; Álvarez Forero, Lina Mercedes; Tovar, Lina Ximena; Herrera, Liz Karen; Acevedo, Liza; Domínguez, Lorena Daniela; Zapata Orduz, Luis Eduardo; Beltrán, Luisa Fernanda; Rincón Romo, Luisa María; Castillo Cifuentes, Luz Adriana; Ballesteros Rueda, Luz M.; Toloza Blanco, Lyzed; Vélez Castro, Manuela; Patiño Lagos, Margareth Andrea; Acevedo Morantes, María; Penayo, María Cristina; Hernández Carrión, María; Rocha Barbosa Schiavon, Maria Ingrid; Wolf Maciel, Maria Regina; Rodríguez, María; Noriega Valencia, Mario Andrés; Velásquez Lozano, Mario Enrique; Montes Garcés, Mario; Cuenca, Marta; Posada Buitrago, Martha Lucía; Arias Tapias, Mary Judith; Arias Ocampo, Mayra Alejandra; Xavier Gonçalves, Mellany Paula; Durán, Melvin Aroldo; Durán Rincón, Melvin; Vera Mahecha, Mercedes; Ramírez Rodríguez, Michael; Carrillo Hernández, Miguel Ángel; Camelo Díaz, Milthon Esteban; Gagliardi Khouri, Nadia; Toscano Miranda, Nahieh; Rodríguez Salamanca, Narella; Giménez, Natalia; Zamudio Muñoz, Natalia Isabel; Peña Mogollón, Nathalia; Ramírez Cuadro, Néstor Eduardo; Ruiz Márquez, Nevis Alejandra; Rincón Téllez, Nicolás; Velásquez Torres, Nicolle Sandler; Pájaro Gómez, Nórida; Moreno, Nubia; Rojas García, Omar; Pillaca Pullo, Omar S.; Àlvarez, Òscar; Prado Rubio, Oscar Andrés; Monroy Quezada, Óscar Javier; Vargas, Óscar; Acevedo, Paola; Bautista Duarte, Paola; Maradei, Paola; Ardila González, Paula Gixina; Meza Castellar, Pedro Javier; Peláez Sánchez, Pedro Pablo; Gañán, Piedad; Malagón, Rafael Eduardo; Gamero, Rafael; Mendoza Rodríguez, Rafael José; Vieira Da Silva Jr., Rinaldo; Ortega Toro, Rodrigo; Acosta, Rolando; Mendoza, Rolando; Williams Vicente, Roldán Carbajal; Mercado Ojeda, Ronald Alfonso; Acosta, Ruben; Acosta Velasquez, Ruben Dario; Durango, Rubén; Maciel Filho, Rubens; Lancheros, Ruth; Arenas Moreno, Saaibi de Jesús; Meramo Hurtado, Samir; Muñoz-Navarro, Samuel Fernando; Bautista Rodriguez, Sandra; Bedoya Barrera, Santiago; Vera Aguirre, Sara Marcela; Vecino Mantilla, Sebastián; Enrique Rozo, Sergio; Terán Castro, Sergio; Garzón, Sharol; Duarte, Shirley Johanna; Rincón, Sonia; Camacaro, Stephany; Tobar, Tatiana A.; Caballero Sarmiento, Valentina; Erazo, Valentina; Méndez Jiménez, Valentina; Robledo Rella, Víctor; Cárdenas Concha, Viktor Oswaldo; Contreras Ortega, Vilmaris; Escalante, Waldir Estela; Flórez Escobar, Whady Felipe; Silva, Wilber; Fajardo Moreno, William Stive; Marchioli, Willian; Oyola, Wilson G.; Hideki Hirota, Wilson; Tulcán Cuasapud, Yanela Alexandra; Morales Cortés, Yenny Paola; López, Yhonattan Nicolás; Torres, Yusleivis
Academic Journal
Zapata, Wildeman; Serna-Arbeláez, Maria S.; Florez-Sampedro, Laura; Orozco, Lina P.; Ramírez, Katherin; Galeano, Elkin; Zapata Builes, Wildeman
Adv Virol
Advances in Virology, Vol 2021 (2021)
[1]S . G. Deeks, S . R. Lewin, and D. V. Havlir, “+e end of AIDS: HIV infection as a chronic disease,” ?e Lancet, vol. 382, no. 9903, pp. 1525–1533, 2013
[2] UNAIDS, Global HIV & AIDS Statistics-2020 Fact Sheet, UNAIDS, Geneva, Switzerland, unaids.org2020, 2020.
[3]S . B. Laskey and R. F. Siliciano, “A mechanistic theory to explain the efficacy of antiretroviral therapy,” Nature Reviews Microbiology, vol. 12, no. 11, pp. 772–780, 2014.
[4] T. B. Ng, B. Huang, W. P. Fong, and H. W. Yeung, “Antihuman immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors,” Life Sciences, vol. 61, no. 10, pp. 933–949, 1997.
[5] Panel on Antiretroviral Guidelines for Adults and Adolescents, Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, Department of Health and Human Services, Washington, DC, USA, 2019.
[6] Organization WH, Guideline on when to Start Antiretroviral ?erapy and on Pre-exposure Prophylaxis for HIV, 78 pages, World Health Organization, Geneva, Switzerland, 2015.
[7] D. King,S . Tomkins, A. Waters et al., “Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects,” Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 1081–1087, 2005
[8] J. Stekler, J. Maenza, C. Stevens et al., “Abacavir hypersensitivity reaction in primary HIV infection,” Aids, vol. 20, no. 9, pp. 1269–1274, 2006.
[9] B.S . Peters and K. Conway, “+erapy for HIV,” Advances in Dental Research, vol. 23, no. 1, pp. 23–27, 2011.
[10] V. Montessori, N. Press, M. Harris, L. Akagi, and J.S . Montaner, “Adverse effects of antiretroviral therapy for HIV infection,” CMAJ: Canadian Medical Association Journal, vol. 170, no. 2, pp. 229–238, 2004.
[11]S . Esser, D. Helbig, U. Hillen, J. Dissemond, and S . Grabbe, “Side effects of HIV therapy,” JDDG, vol. 5, no. 9, pp. 745–754, 2007
[12] L. Menendez-Arias, “Targeting HIV: antiretroviral therapy ´ and development of drug resistance,” Trends in Pharmacological Sciences, vol. 23, no. 8, pp. 381–388, 2002.
[13] E. M. Gardner, W. J. Burman, J. F. Steiner, P. L. Anderson, and D. R. Bangsberg, “Antiretroviral medication adherence and the development of class-specific antiretroviral resistance,” AIDS, vol. 23, no. 9, pp. 1035–1046, 2009
[14] J. B. Nachega, V. C. Marconi, G. U. van Zyl et al., “HIV treatment adherence, drug resistance, virologic failure: evolving concepts,” Infectious Disorders Drug Targets, vol. 11, no. 2, pp. 167–174, 2011.
[15] P. Yeni, “Update on HAART in HIV,” Journal of Hepatology, vol. 44, 2006
[16] F. Nakagawa, A. Miners, C. J. Smith et al., “Projected lifetime healthcare costs associated with HIV infection,” PLoS One, vol. 10, no. 4, Article ID e0125018, 2015.
[17] N. E. +omford, D. A. Senthebane, A. Rowe et al., “Natural products for drug discovery in the 21st century: innovations for novel drug discovery,” International Journal of Molecular Sciences, vol. 19, no. 6, 2018.
[18] L. Palmisano andS . Vella, “A brief history of antiretroviral therapy of HIV infection: success and challenges,” Annali dell’Istituto Superiore di Sanita, vol. 47, no. 1, pp. 44–48, 2011.
[19] K. Vermani andS . Garg, “Herbal medicines for sexually transmitted diseases and AIDS,” Journal of Ethnopharmacology, vol. 80, no. 1, pp. 49–66, 2002.
[20] D. Chattopadhyay, M. C. Sarkar, T. Chatterjee et al., “Recent advancements for the evaluation of anti-viral activities of natural products,” New Biotechnology, vol. 25, no. 5, pp. 347–368, 2009.
[21] K. Yazaki, G.-i. Arimura, and T. Ohnishi, “Hidden’ terpenoids in plants: their biosynthesis, localization and ecological roles,” Plant and Cell Physiology, vol. 58, no. 10, pp. 1615–1621, 2017
[22] D. +oll, “Biosynthesis and biological functions of terpenoids in plants,” Biotechnology of Isoprenoids, vol. 148, pp. 63–106, 2015.
[23] J.-H. Yu, G.-C. Wang, Y.-S . Han, Y. Wu, M. A. Wainberg, and J.-M. Yue, “Limonoids with anti-HIV activity from Cipadessa cinerascens,” Journal of Natural Products, vol. 78, no. 6, pp. 1243–1252, 2015.
[24] M. Shahidul Alam, M. A. Quader, and M. A. Rashid, “HIVinhibitory diterpenoid from Anisomeles indica,” Fitoterapia, vol. 71, no. 5, pp. 574–576, 2000.
[25]S .-Z. Huang, X. Zhang, Q.-Y. Ma et al., “Terpenoids and their anti-HIV-1 activities from Excoecaria acerifolia,” Fitoterapia, vol. 91, pp. 224–230, 2013.
[26]S .-Z. Huang, X. Zhang, Q.-Y. Ma et al., “Anti-HIV-1 tigliane diterpenoids from Excoecaria acertiflia Didr,” Fitoterapia, vol. 95, pp. 34–41, 2014.[27] S .-F. Li, Y. Zhang, N. Huang et al., “Daphnane diterpenoids from the stems of Trigonostemon lii and their anti-HIV-1 activity,” Phytochemistry, vol. 93, pp. 216–221, 2013.
[28] Y.-Y. Cheng, H. Chen, H.-P. He et al., “Anti-HIV active daphnane diterpenoids from Trigonostemon thyrsoideum,” Phytochemistry, vol. 96, pp. 360–369, 2013.
[29] T. Fujioka, Y. Kashiwada, R. E. Kilkuskie et al., “Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids,” Journal of Natural Products, vol. 57, no. 2, pp. 243–247, 1994.
[30] T. Kanamoto, Y. Kashiwada, K. Kanbara et al., “Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 4, pp. 1225–1230, 2001.
[31] F. Li, R. Goila-Gaur, K. Salzwedel et al., “PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing,” Proceedings of the National Academy of Sciences, vol. 100, no. 23, pp. 13555–13560, 2003.
[32] Y. Zhao, Q. Gu,S . L. Morris-Natschke, C.-H. Chen, and K.-H. Lee, “Incorporation of privileged structures into bevirimat can improve activity against wild-type and bevirimat-resistant HIV-1,” Journal of Medicinal Chemistry, vol. 59, no. 19, pp. 9262–9268, 2016.
[33] F. Soler, C. Poujade, M. Evers et al., “Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry,” Journal of Medicinal Chemistry, vol. 39, no. 5, pp. 1069–1083, 1996.
[34] J. Tang,S . A. Jones, J. L. Jeffrey et al., “Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms,” Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 12, pp. 2689–2694, 2017.
[35] H.-X. Xu, F.-Q. Zeng, M. Wan, and K.-Y. Sim, “Anti-HIV triterpene acids fromGeum japonicum,” Journal of Natural Products, vol. 59, no. 7, pp. 643–645, 1996.
[36] Y. Kashiwada, T. Nagao, A. Hashimoto et al., “Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid Derivatives1,” Journal of Natural Products, vol. 63, no. 12, pp. 1619–1622, 2000
[37] N. Kongkum, P. Tuchinda, M. Pohmakotr et al., “Cytotoxic, antitopoisomerase IIα, and anti-HIV-1 activities of triterpenoids isolated from leaves and twigs of Gardenia carinata,” Journal of Natural Products, vol. 76, no. 4, pp. 530–537, 2013.
[38]S . el-Mekkawy, M. R. Meselhy, N. Nakamura et al., “AntiHIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum,” Phytochemistry, vol. 49, no. 6, pp. 1651–1657, 1998.
[39] B.-S . Min, N. Nakamura, H. Miyashiro, K.-W. Bae, and M. Hattori, “Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease,” Chemical and Pharmaceutical Bulletin, vol. 46, no. 10, pp. 1607–1612, 1998
[40] T. Konoshima, I. Yasuda, Y. Kashiwada, L. M. Cosentino, and K.-H. Lee, “Anti-AIDS agents, 21. Triterpenoid saponins as anti-HIV principles from fruits of gleditsia japonica and gymnocladus chinesis, and a structure-activity correlation,” Journal of Natural Products, vol. 58, no. 9, pp. 1372–1377, 1995.
[41] Y. Kashman, K. R. Gustafson, R. W. Fuller et al., “HIV inhibitory natural products. Part 7. +e calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum,” Journal of Medicinal Chemistry, vol. 35, no. 15, pp. 2735–2743, 1992.
[42] M. Huerta-Reyes, M. d. C. Basualdo, F. Abe, M. JimenezEstrada, C. Soler, and R. Reyes-Chilpa, “HIV-1 inhibitory compounds from Calophyllum brasiliense leaves,” Biological and Pharmaceutical Bulletin, vol. 27, no. 9, pp. 1471–1475, 2004
[43] A. D. Patil, A. J. Freyer, D.S . Eggleston et al., “+e inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn,” Journal of Medicinal Chemistry, vol. 36, no. 26, pp. 4131–4138, 1993.
[44] H. Dharmaratne, W. Wanigasekera, E. Mata-Greenwood, and J. Pezzuto, “Inhibition of human immunodeficiency virus type 1 reverse transcriptase activity by cordatolides isolated fromCalophyllum cordato-oblongum,” Planta Medica, vol. 64, no. 05, pp. 460-461, 1998.
[45] H. R. W. Dharmaratne, G. T. Tan, G. P. K. Marasinghe, and J. M. Pezzuto, “Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones,” Planta Medica, vol. 68, no. 1, pp. 86-87, 2002.
[46] E. Kudo, M. Taura, K. Matsuda et al., “Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 3, pp. 606–609, 2013.
[47] P. Zhou, Y. Takaishi, H. Duan et al., “Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release,” Phytochemistry, vol. 53, no. 6, pp. 689–697, 2000.
[48] N. Marquez, R. Sancho, L. M. Bedoya et al., “Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway,” Antiviral Research, vol. 66, no. 2-3, pp. 137–145, 2005.
[49] Q. Wang, Z. Ding, J. Liu, and Y. Zheng, “Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus,” Antiviral Research, vol. 64, no. 3, pp. 189–194, 2004.
[50] D. C. Rowley, M.S . T. Hansen, D. Rhodes et al., “+alassiolins A-C: new marine-derived inhibitors of HIV cDNA integrase,” Bioorganic & Medicinal Chemistry, vol. 10, no. 11, pp. 3619–3625, 2002
[51] N. Mahmood, C. Pizza, R. Aquino et al., “Inhibition of HIV infection by flavanoids,” Antiviral Research, vol. 22, no. 2-3, pp. 189–199, 1993.
[52]S . Li, T. Hattori, and E. N. Kodama, “Epigallocatechin gallate inhibits the HIV reverse transcription step,” Antiviral Chemistry and Chemotherapy, vol. 21, no. 6, pp. 239–243, 2011.
[53] K. Kitamura, M. Honda, H. Yoshizaki et al., “Baicalin, an inhibitor of HIV-1 production in vitro,” Antiviral Research, vol. 37, no. 2, pp. 131–140, 1998.
[54] B. Q. Li, T. Fu, Y. Dongyan, J. A. Mikovits, F. W. Ruscetti, and J. M. Wang, “Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry,” Biochemical and Biophysical Research Communications, vol. 276, no. 2, pp. 534–538, 2000.
[55]S . Pasetto, V. Pardi, and R. M. Murata, “Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model,” PLoS One, vol. 9, no. 12, Article ID e115323, 2014.
[56] P. Chaniad, C. Wattanapiromsakul,S . Pianwanit, and S . Tewtrakul, “Anti-HIV-1 integrase compounds fromDioscorea bulbiferaand molecular docking study,” Pharmaceutical Biology, vol. 54, no. 6, pp. 1077–1085, 2016
[57] J. T. Ortega, A. I. Suarez, M. L. Serrano, J. Baptista, F. H. Pujol, and H. R. Rangel, “+e role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro,” AIDS Research and ?erapy, vol. 14, no. 1, 57 pages, 2017.
[58] A. Mazumder, K. Raghavan, J. Weinstein, K. W. Kohn, and Y. Pommier, “Inhibition of human immunodeficiency virus type-1 integrase by curcumin,” Biochemical Pharmacology, vol. 49, no. 8, pp. 1165–1170, 1995.
[59] A. Mazumder, N. Neamati,S . Sunder et al., “Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action,” Journal of Medicinal Chemistry, vol. 40, no. 19, pp. 3057– 3063, 1997.
[60] N. Kumari, A. A. Kulkarni, X. Lin et al., “Inhibition of HIV-1 by curcumin A, a novel curcumin analog,” Drug Design, Development and ?erapy, vol. 9, pp. 5051–5060, 2015.
[61] R. A. Reinke, D. J. Lee, B. R. McDougall et al., “L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro,” Virology, vol. 326, no. 2, pp. 203–219, 2004.
[62] Y.-J. Zou, H.-X. Wang, T.-B. Ng, C.-Y. Huang, and J.-X. Zhang, “Purification and characterization of a novel laccase from the edible mushroom Hericium coralloides,” ?e Journal of Microbiology, vol. 50, no. 1, pp. 72–78, 2012.
[63] H. X. Wang and T. B. Ng, “A new laccase from dried fruiting bodies of the monkey head mushroom Hericium erinaceum,” Biochemical and Biophysical Research Communications, vol. 322, no. 1, pp. 17–21, 2004.
[64] M. Li, G. Zhang, H. Wang, and T. Ng, “Purification and characterization of a laccase from the edible wild mushroom Tricholoma mongolicum,” Journal of Microbiology and Biotechnology, vol. 20, no. 7, pp. 1069–1076, 2010.
[65] H. X. Wang and T. B. Ng, “A laccase from the medicinal mushroom Ganoderma lucidum,” Applied Microbiology and Biotechnology, vol. 72, no. 3, pp. 508–513, 2006
[66] J. Sun, Q. J. Chen, Q. Q. Cao et al., “A laccase with antiproliferative and HIV-I reverse transcriptase inhibitory activities from the mycorrhizal fungus Agaricus placomyces,” Journal of Biomedicine & Biotechnology, vol. 2012, Article ID 736472, 12 pages, 2012.
[67] D. D. Hu, R. Y. Zhang, G. Q. Zhang, H. X. Wang, and T. B. Ng, “A laccase with antiproliferative activity against tumor cells from an edible mushroom, white common Agrocybe cylindracea,” Phytomedicine, vol. 18, no. 5, pp. 374–379, 2011
[68] H. X. Wang and T. B. Ng, “Purification of a novel lowmolecular-mass laccase with HIV-1 reverse transcriptase inhibitory activity from the mushroom Tricholoma giganteum,” Biochemical and Biophysical Research Communications, vol. 315, no. 2, pp. 450–454, 2004.
[69]S . Zhao, C. B. Rong, C. Kong et al., “A novel laccase with potent antiproliferative and HIV-1 reverse transcriptase inhibitory activities from mycelia of mushroom Coprinus comatus,” BioMed Research International, vol. 2014, Article ID 417461, 8 pages, 2014.
[70] X. Wu, C. Huang, Q. Chen, H. Wang, and J. Zhang, “A novel laccase with inhibitory activity towards HIV-I reverse transcriptase and antiproliferative effects on tumor cells from the fermentation broth of mushroomPleurotus cornucopiae,” Biomedical Chromatography, vol. 28, no. 4, pp. 548–553, 2014.
[71] J. H. Wong, T. B. Ng, Y. Jiang, F. Liu,S . C. Sze, and K. Y. Zhang, “Purification and characterization of a Laccase with inhibitory activity toward HIV-1 reverse transcriptase and tumor cells from an edible mushroom (Pleurotus cornucopiae),” Protein and Peptide Letters, vol. 17, no. 8, pp. 1040–1047, 2010.
[72] G.-Q. Zhang, Y.-F. Wang, X.-Q. Zhang, T. B. Ng, and H.-X. Wang, “Purification and characterization of a novel laccase from the edible mushroom Clitocybe maxima,” Process Biochemistry, vol. 45, no. 5, pp. 627–633, 2010.
[73] L. Xu, H. Wang, and T. Ng, “A laccase with HIV-1 reverse transcriptase inhibitory activity from the broth of mycelial culture of the mushroom Lentinus tigrinus,” BioMed Research International, vol. 2012, Article ID 536725, 7 pages, 2012.
[74] J. Sun, H. Wang, and T. B. Ng, “Isolation of a laccase with HIV-1 reverse transcriptase inhibitory activity from fresh fruiting bodies of the Lentinus edodes (Shiitake mushroom),” Indian Journal of Biochemistry & Biophysics, vol. 48, no. 2, pp. 88–94, 2011.
[75] H. X. Wang and T. B. Ng, “Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases,” Planta Medica, vol. 67, no. 7, pp. 669–672, 2001.
[76] J. Balzarini, D. Schols, J. Neyts, E. Van Damme, W. Peumans, and E. De Clercq, “Alpha-(1-3)-and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro,” Antimicrobial Agents and Chemotherapy, vol. 35, no. 3, pp. 410–416, 1991.
[77] J. Balzarini, J. Neyts, D. Schols et al., “+e mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro,” Antiviral Research, vol. 18, no. 2, pp. 191–207, 1992.
[78] R. D. Charan, M. H. G. Munro, B. R. O’Keefe et al., “Isolation and characterization ofMyrianthus holstiiLectin, a potent HIV-1 inhibitory protein from the PlantMyrianthus holstii1,” Journal of Natural Products, vol. 63, no. 8, pp. 1170–1174, 2000
[79] G. Ferir, D. Huskens,S . Noppen, L. M. I. Koharudin, ´ A. M. Gronenborn, and D. Schols, “Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 10, pp. 2746–2758, 2014.
[80] T. Mori, B. R. O’Keefe, R. C. Sowder 2nd. et al., “Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp,” Journal of Biological Chemistry, vol. 280, no. 10, pp. 9345–9353, 2005.
[81]S . Zhao, Y. Zhao, S . Li et al., “A novel lectin with highly potent antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the edible wild mushroom Russula delica,” Glycoconjugate Journal, vol. 27, no. 2, pp. 259–265, 2010.
[82] Y. R. Li, Q. H. Liu, H. X. Wang, and T. B. Ng, “A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus,” Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1780, no. 1, pp. 51–57, 2008.
[83] C. H. Han, Q. H. Liu, T. B. Ng, and H. X. Wang, “A novel homodimeric lactose-binding lectin from the edible split gill medicinal mushroom Schizophyllum commune,” Biochemical and Biophysical Research Communications, vol. 336, no. 1, pp. 252–257, 2005.
[84] G. Q. Zhang, J. Sun, H. X. Wang, and T. B. Ng, “A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa,” Acta Biochimica Polonica, vol. 56, no. 3, pp. 415–421, 2009.
[85] J. K. Zhao, H. X. Wang, and T. B. Ng, “Purification and characterization of a novel lectin from the toxic wild mushroom Inocybe umbrinella,” Toxicon, vol. 53, no. 3, pp. 360–366, 2009.
[86]S . Zheng, C. Li, T. B. Ng, and H. X. Wang, “A lectin with mitogenic activity from the edible wild mushroom Boletus edulis,” Process Biochemistry, vol. 42, no. 12, pp. 1620–1624, 2007.
[87] Y. Li, G. Zhang, T. B. Ng, and H. Wang, “A novel lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from dried fruiting bodies of the monkey head mushroom Hericium erinaceum,” BioMed Research International, vol. 2010, Article ID 716515, 9 pages, 2010.
[88] H. Wang and T. B. Ng, “Isolation and characterization of velutin, a novel low-molecular-weight ribosome-inactivating protein from winter mushroom (Flammulina velutipes) fruiting bodies,” Life Sciences, vol. 68, no. 18, pp. 2151–2158, 2001.
[89]S . K. Lam and T. B. Ng, “First simultaneous isolation of a ribosome inactivating protein and an antifungal protein from a mushroom (Lyophyllum shimeji) together with evidence for synergism of their antifungal effects,” Archives of Biochemistry and Biophysics, vol. 393, no. 2, pp. 271–280, 2001
[90]S . K. Lam and T. B. Ng, “Hypsin, a novel thermostable ribosome-inactivating protein with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus,” Biochemical and Biophysical Research Communications, vol. 285, no. 4, pp. 1071–1075, 2001.
[91] J. H. Wong, H. X. Wang, and T. B. Ng, “Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus,” Applied Microbiology and Biotechnology, vol. 81, no. 4, pp. 669–674, 2008
[92] Y.-M. Ng, Y. Yang, K.-H. Sze, X. Zhang, Y.-T. Zheng, and P.-C. Shaw, “Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindrica),” Journal of Structural Biology, vol. 174, no. 1, pp. 164–172, 2011.
[93] I. Kaur, M. Puri, Z. Ahmed, F. P. Blanchet, B. Mangeat, and V. Piguet, “Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina,” PLoS One, vol. 8, no. 9, Article ID e73780, 2013.
[94] F. Rajamohan, T. K. Venkatachalam, J. D. Irvin, and F. M. Uckun, “Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1,” Biochemical and Biophysical Research Communications, vol. 260, no. 2, pp. 453–458, 1999.
[95] T. Ichiba, P. J. Scheuer, M. Kelly-borges, and F. Pierce, “+ree bromotyrosine derivatives, one terminating in an unprecedented diketocyclopentenylidene enamine,” ?e Journal of Organic Chemistry, vol. 58, no. 15, pp. 4149-4150, 1993.
[96] D. Gochfeld, K. El Sayed, M. Yousaf et al., “Marine natural products as lead anti-HIV agents,” Mini-Reviews in Medicinal Chemistry, vol. 3, no. 5, pp. 401–424, 2003.
[97] L. G. G´omez-Archila, W. Zapata, F. J. D´ıaz, M. T. Rugeles, E. Galeano, and A. Mart´ınez, “Bromotyrosine derivatives from marine sponges inhibit the HIV-1 replication in vitro,” Vitae, vol. 21, no. 2, pp. 114–125, 2014
[98]S . A. Ross, J. D. Weete, R. F. Schinazi et al., “Mololipids, A new series of anti-HIV bromotyramine-derived compounds from a sponge of the order Verongida†,” Journal of Natural Products, vol. 63, no. 4, pp. 501–503, 2000.
[99] P. Yogeeswari and D. Sriram, “Betulinic acid and its derivatives: a review on their biological properties,” Current Medicinal Chemistry, vol. 12, no. 6, pp. 657–666, 2005.
[100] D. E. Martin, R. Blum, J. Wilton et al., “Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 9, pp. 3063–3066, 2007.
[101] D. E. Martin, R. Blum, J. Doto, H. Galbraith, and C. Ballow, “Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV Maturation, in healthy volunteers,” Clinical Pharmacokinetics, vol. 46, no. 7, pp. 589–598, 2007.
[102] P. F. Smith, A. Ogundele, A. Forrest et al., “Phase I and II study of the safety, virologic effect, and pharmacokinetics/ pharmacodynamics of single-dose 3-O-(3′,3′-Dimethylsuccinyl)Betulinic acid (bevirimat) against human immunodeficiency virus infection,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 10, pp. 3574–3581, 2007.
[103] N. A. Margot, C.S . Gibbs, and M. D. Miller, “Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 6, pp. 2345–2353, 2010.
[104] A. Neyret, B. Gay, A. Cransac et al., “Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation,” Antiviral Research, vol. 164, pp. 162–175, 2019.
[105] B. Labrosse, O. Pleskoff, N. Sol, C. Jones, Y. H´enin, and M. Alizon, “Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41,” Journal of Virology, vol. 71, no. 11, pp. 8230–8236, 1997.
[106] B. Labrosse, C. Treboute, and M. Alizon, “Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region,” Journal of Virology, vol. 74, no. 5, pp. 2142–2150, 2000.
[107] I. Kostova,S . Raleva, P. Genova, and R. Argirova, “Structureactivity relationships of synthetic coumarins as HIV-1 inhibitors,” Bioinorganic Chemistry and Applications, vol. 2006, Article ID 68274, 9 pages, 2006.
[108] B. Chenera, M. L. West, J. A. Finkelstein, and G. B. Dreyer’, “Total synthesis of (±)-calanolide A, a non-nucleoside inhibitor of HIV-1 reverse transcriptase,” ?e Journal of Organic Chemistry, vol. 58, no. 21, 1993.
[109] A. Kucherenko, M. T. Flavin, W. A. Boulanger et al., “Novel approach for synthesis of (±)-calanolide a and its anti-HIV activity,” Tetrahedron Letters, vol. 36, no. 31, 1995.
[110] M. T. Flavin, “Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (±)-Calanolide A and its enantiomers,” Journal of Medicinal Chemistry, vol. 39, no. 6, 1995
[111] J. H. Cardellina, H. R. Bokesch, T. C. McKee, and M. R. Boyd, “Resolution and comparative anti-HIV evaluation of the enantiomers of calanolides A and B,” Bioorganic & Medicinal Chemistry Letters, vol. 5, no. 9, pp. 1011–1014, 1995
[112] R. W. Buckheit Jr., E. L. White, V. Fliakas-Boltz et al., “Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 8, pp. 1827–1834, 1999
[113] R. Buckheit Jr., V. Fliakasboltz, W. Decker et al., “Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups,” Antiviral Research, vol. 26, no. 2, pp. 117–132, 1995.
[114] J. C. Garc´ıa Zebad´ua, G. A. Magos Guerrero, M. Mumbr´u Massip et al., “Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico,” Fitoterapia, vol. 82, no. 7, pp. 1027–1034, 2011.
[115] T. Creagh, J. L. Ruckle, D. T. Tolbert et al., “Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 5, pp. 1379–1386, 2001.
[116] D. A. Eiznhamer, T. Creagh, J. L. Ruckle et al., “Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers,” HIV Clinical Trials, vol. 3, no. 6, pp. 435–450, 2002.
[117] K. Matsuda,S . Hattori, R. Kariya et al., “Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity,” Biochemical and Biophysical Research Communications, vol. 457, no. 3, pp. 288–294, 2015
[118] H. Wang, Y. Liu, C. Huan et al., “NF-κB-Interacting long noncoding RNA regulates HIV-1 replication and latency by repressing NF-κB signaling,” Journal of Virology, vol. 94, no. 17, 2020.
[119] P. Bremner and M. Heinrich, “Natural products as targeted modulators of the nuclear factor-kappaB pathway,” ?e Journal of Pharmacy and Pharmacology, vol. 54, no. 4, pp. 453–472, 2002.
[120] M. Karin, Y. Yamamoto, and Q. M. Wang, “+e IKK NF-κB system: a treasure trove for drug development,” Nature Reviews Drug Discovery, vol. 3, no. 1, pp. 17–26, 2004.
[121] R. Sancho, N. Marquez, M. G ´ omez-Gonzalo et al., ´ “Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway,” Journal of Biological Chemistry, vol. 279, no. 36, pp. 37349–37359, 2004.
[122] E. Kozioł and K. Skalicka-Woz´niak, “Imperatorin–pharmacological meaning and analytical clues: profound investigation,” Phytochemistry Review, vol. 15, pp. 627–649, 2016.
[123] M. Deng, L. Xie, L. Zhong, Y. Liao, L. Liu, and X. Li, “Imperatorin: a review of its pharmacology, toxicity and pharmacokinetics,” European Journal of Pharmacology, vol. 879, 2020.
[124] G. Casano, A. Dum`etre, C. Pannecouque,S . Hutter, N. Azas, and M. Robin, “Anti-HIV and antiplasmodial activity of original flavonoid derivatives,” Bioorganic & Medicinal Chemistry, vol. 18, no. 16, pp. 6012–6023, 2010.
[125] T. P. T. Cushnie and A. J. Lamb, “Antimicrobial activity of flavonoids,” International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 343–356, 2005.
[126] X. Zhao, K. Jiang, B. Liang, and X. Huang, “Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway,” Oncology Reports, vol. 35, no. 2, pp. 669–675, 2016.
[127] B. W. Vanhoecke, F. Delporte, E. Van Braeckel et al., “A safety study of oral tangeretin and xanthohumol administration to laboratory mice,” Vivo, vol. 19, no. 1, pp. 103–107, 2005.
[128] K. Yamaguchi, M. Honda, H. Ikigai, Y. Hara, and T. Shimamura, “Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1),” Antiviral Research, vol. 53, no. 1, pp. 19–34, 2002.
[129] K. Kawai, N. H. Tsuno, J. Kitayama et al., “Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding,” Journal of Allergy and Clinical Immunology, vol. 112, no. 5, pp. 951–957, 2003.
[130] C. L. Nance, E. B. Siwak, and W. T. Shearer, “Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy,” Journal of Allergy and Clinical Immunology, vol. 123, no. 2, pp. 459–465, 2009.
[131] P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, “Bioavailability of curcumin: problems and promises,” Molecular Pharmaceutics, vol. 4, no. 6, pp. 807–818, 2007.
[132] C. J. Li, L. J. Zhang, B. J. Dezube, C.S . Crumpacker, and A. B. Pardee, “+ree inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication,” Proceedings of the National Academy of Sciences, vol. 90, no. 5, pp. 1839–1842, 1993.
[133] A. Ali and A. C. Banerjea, “Curcumin inhibits HIV-1 by promoting Tat protein degradation,” Scientific Reports, vol. 627539 pages, 2016.
[134] A. L. Cheng, C. H. Hsu, J. K. Lin et al., “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with highrisk or pre-malignant lesions,” Anticancer Research, vol. 21, no. 4b, pp. 2895–2900, 2001.
[135] G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. Srinivas, “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers,” Planta Medica, vol. 64, no. 4, pp. 353–356, 1998.
[136] P. Baldrian, “Fungal laccases-occurrence and properties,” FEMS Microbiology Reviews, vol. 30, no. 2, pp. 215–242, 2006.
[137] P. Giardina, V. Faraco, C. Pezzella, A. Piscitelli,S . Vanhulle, and G. Sannia, “Laccases: a never-ending story,” Cellular and Molecular Life Sciences, vol. 67, no. 3, pp. 369–385, 2010.
[138] M. Bottcher and F. Grosse, “HIV-1 protease inhibits its ¨ homologous reverse transcriptase by protein-protein interaction,” Nucleic Acids Research, vol. 25, pp. 1709–1714, 1997
[139] T. B. Ng and H. X. Wang, “A homodimeric laccase with unique characteristics from the yellow mushroom Cantharellus cibarius,” Biochemical and Biophysical Research Communications, vol. 313, no. 1, pp. 37–41, 2004.
[140] H. X. Wang and T. B. Ng, “A novel laccase with fair thermostability from the edible wild mushroom (Albatrella dispansus),” Biochemical and Biophysical Research Communications, vol. 319, no. 2, pp. 381–385, 2004.
[141] A. E. Franco Molano and E. Uribe-Calle, “Hongos agricales y boletales de Colombia,” Biota Colombiana, vol. 1, no. 1, pp. 25–43, 2000.
[142] C. Arboleda, A. I. Mej´ıa, A. E. Franco-Molano, G. A. Jim´enez, and J. Pm, “Autochthonous white rot fungi from the tropical forest of Colombia for dye decolourisation and ligninolytic enzymes production,” Sydowia, vol. 60, no. 2, pp. 165–180, 2008.
[143] A. Ruiz and A. Varela, “Nuevos registros de Aphyllophorales (Basidiomicota) en bosque montano h´umedo y de niebla de Colombia,” Caldasia, vol. 28, no. 2, pp. 259–266, 2006.
[144] L. Florez-sampedro, W. Zapata, W. Zapata et al., “In vitro ´ anti-HIV-1 activity of the enzymatic extract enriched with laccase produced by the fungi ganoderma sp. and lentinus sp,” Revista Vitae, vol. 23, no. 2, pp. 109–118, 2016.
[145] R. Goldstein Ijh, M. Monsigny, T. Osawa, and N. Sharon, “What should be called a lectin?” Nature, vol. 285, no. 66, 1980.
[146] H. Wang, T. B. Ng, and V. E. C. Ooi, “Lectins from mushrooms,” Mycological Research, vol. 102, no. 8, pp. 897–906, 1998.
[147] J. Guillot and G. Konska, “Lectins in higher fungi,” Biochemical Systematics and Ecology, vol. 25, no. 3, pp. 203–230, 1997.
[148] H. X. Wang, T. B. Ng, W. K. Liu, V. E. Ooi, andS . T. Chang, “Isolation and characterization of two distinct lectins with antiproliferative activity from the cultured mycelium of the edible mushroom Tricholoma mongolicum,” International Journal of Peptide and Protein Research, vol. 46, no. 6, pp. 508–513, 1995.
[149] P. H. K. Ngai and T. B. Ng, “Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells,” Life Sciences, vol. 73, no. 26, pp. 3363–3374, 2003.
[150] H. Wang, T. B. Ng, and Q. Liu, “Isolation of a new heterodimeric lectin with mitogenic activity from fruiting bodies of the mushroom Agrocybe cyli
[151] Q.-B. She, T.-B. Ng, and W.-K. Liu, “A novel lectin with potent immunomodulatory activity isolated from both fruiting bodies and cultured mycelia of the edible MushroomVolvariella volvacea,” Biochemical and Biophysical Research Communications, vol. 247, no. 1, pp. 106–111, 1998
[152]S . Sueyoshi, T. Tsuji, and T. Osawa, “Purification and characterization of four isolectins of mushroom (Agaricus bisporus),” Biol Chem Hoppe Seyler, vol. 366, no. 3, pp. 213–221, 1985
[153]S . Oguri, M. Yoshida, and Y. Nagata, “Isolation, crystallization, and characterization of a 16.5-kDa protein from fruit bodies of a lectin-deficient strain ofPleurotus cornucopiae,” Bioscience, Biotechnology, and Biochemistry, vol. 58, no. 3, pp. 502–506, 1994
[154] T.-S . Vo and S .-K. Kim, “Potential anti-HIV agents from marine resources: an overview,” Marine Drugs, vol. 8, no. 12, pp. 2871–2892, 2010.
[155] M. D. Swanson, H. C. Winter, I. J. Goldstein, and D. M. Markovitz, “A lectin isolated from bananas is a potent inhibitor of HIV replication,” Journal of Biological Chemistry, vol. 285, no. 12, pp. 8646–8655, 2010.
[156] T. Mori, B. R. O’Keefe, R. C. Sowder 2nd. et al., “Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp,” Journal of Biological Chemistry, vol. 280, no. 10, pp. 9345–9353, 2004.
[157] K. B. Alexandre, E.S . Gray, B. E. Lambson et al., “Mannoserich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin,” Virology, vol. 402, no. 1, pp. 187–196, 2010.
[158] P. Emau, B. Tian, B. R. O’keefe et al., “Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide,” Journal of Medical Primatology, vol. 36, no. 4-5, pp. 244–253, 2007.
[159] B. R. O’Keefe, F. Vojdani, V. Buffa et al., “Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component,” Proceedings of the National Academy of Sciences, vol. 106, no. 15, pp. 6099–6104, 2009
[160] J. C. Kouokam, D. Huskens, D. Schols et al., “Investigation of griffithsin’s interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate,” PLoS One, vol. 6, no. 8, Article ID e22635, 2011.
[161] C. Barton, J. C. Kouokam, A. B. Lasnik et al., “Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 1, pp. 120–127, 2014.
[162] G. Ferir, K. E. Palmer, and D. Schols, “Synergistic activity ´ profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C,” Virology, vol. 417, no. 2, pp. 253–258, 2011.
[163] L. F. Kramzer, K. T. Hamorsky, P. W. Graebing et al., “Preformulation characterization of griffithsin, a biopharmaceutical candidate for HIV prevention,” AAPS PharmSciTech, vol. 22, no. 3, 83 pages, 2021.
[164] G. G¨unaydın, G. Edfeldt, D. A. Garber et al., “Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: in situ analyses of epithelial and immune cell markers in rectal mucosa,” Scientific Reports, vol. 9, no.1, 18120 pages, 2019.
[165] K. R. Crakes, C. Herrera, J. L. Morgan et al., “Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo,” Journal of the International AIDS Society, vol. 23, no. 10, Article ID e25628, 2020.
[166] F. Minooei, J. R. Fried, J. L. Fuqua, K. E. Palmer, and J. M. Steinbach-Rankins, “In vitro study on synergistic interactions between free and encapsulated Q-griffithsin and antiretrovirals against HIV-1 infection,” International Journal of Nanomedicine, vol. 16, pp. 1189–1206, 2021
[167] “Study to evaluate the safety of griffithsin in a carrageenan gel in healthy women clinicaltrials,” 2021, https://clinicaltrials. gov/ct2/show/study/NCT02875119.
[168] “Griffithsin-based rectal microbicide for PREvention of viral ENTry,” 2021, https://clinicaltrials.gov/ct2/show/ NCT04032717
[169] R. A. Collins, T. B. Ng, W. P. Fong, C. C. Wan, and H. W. Yeung, “A comparison of human immunodeficiency virus type 1 inhibition by partially purified aqueous extracts of Chinese medicinal herbs,” Life Sciences, vol. 60, no. 23, pp. Pl345–PL351, 1997.
[170] Q.-Z. Yao, M. M. Yu, L.S . M. Ooi et al., “Isolation and characterization of a type 1 ribosome-inactivating protein from fruiting bodies of the edible mushroom (volvariella volvacea),” Journal of Agricultural and Food Chemistry, vol. 46, no. 2, pp. 788–792, 1998.
[171] T. Girbes, J. Ferreras, F. Arias, and F. Stirpe, “Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria,” Mini-Reviews in Medicinal Chemistry, vol. 4, no. 5, pp. 461–476, 2004
[172]S . A. Kidwai, A. A. Ansari, and A. Salahuddin, “Effect of succinylation (3-carboxypropionylation) on the conformation and immunological activity of ovalbumin,” Biochemical Journal, vol. 155, no. 1, pp. 171–180, 1976
[173] P.-C. Shaw, K.-M. Lee, and K.-B. Wong, “Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties,” Toxicon, vol. 45, no. 6, pp. 683–689, 2005
[174] M.S . McGrath, K. M. Hwang, S . E. Caldwell et al., “GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage,” Proceedings of the National Academy of Sciences, vol. 86, no. 8, pp. 2844–2848, 1989
[175] Y.-Y. Wang, D.-Y. Ouyang, H. Huang, H. Chan,S .-C. Tam, and Y.-T. Zheng, “Enhanced apoptotic action of trichosanthin in HIV-1 infected cells,” Biochemical and Biophysical Research Communications, vol. 331, no. 4, pp. 1075–1080, 2005.
[176] W.-L. Zhao, D. Feng, J. Wu, andS .-F. Sui, “Trichosanthin inhibits integration of human immunodeficiency virus type 1 through depurinating the long-terminal repeats,” Molecular Biology Reports, vol. 37, no. 4, pp. 2093–2098, 2010.
[177] W. Zhao, D. Feng,S . Sun, T. Han, and S . Sui, “+e anti-viral protein of trichosanthin penetrates into human immunodeficiency virus type 1,” Acta Biochimica et Biophysica Sinica, vol. 42, no. 2, pp. 91–97, 2010.
[178] V. Byers, A. Levin, L. Waites et al., “A phase I/II study of trichostathin treatment of HIV desease,” Current Science, vol. 4, no. 2, pp. 1189–1196, 1990.
[179] V.S . Byers, A. S . Levin, A. Malvino, L. Waites, R. A. Robins, and R. W. Baldwin, “A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents,” AIDS Research and Human Retroviruses, vol. 10, no. 4, pp. 413–420, 1994.
[180] J. O. Kahn, K. J. Gorelick, G. Gatti et al., “Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 2, pp. 260–267, 1994.
[181] J. M. Zarling, P. A. Moran, O. Haffar et al., “Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies,” Nature, vol. 347, no. 6288, pp. 92–95, 1990.
[182] J. M. Zarling, P. A. Moran, O. Haffar et al., “Inhibition of HIV-1 replication in seropositive patients’ CD4+ T-cells by pokeweed antiviral protein-monoclonal antibody conjugates,” International Journal of Immunopharmacology, vol. 13, no. 1, pp. 63–68, 1991.
[183] G. Krivdova and K. A. Hudak, “Pokeweed antiviral protein restores levels of cellular APOBEC3G during HIV-1 infection by depurinating Vif mRNA,” Antiviral Research, vol. 122, pp. 51–54, 2015.
[184] M. H. Pastrana Restrepo,S ´ıntesis de derivados clorados y bromados de la l-tirosina y evaluacion in vitro de sus acti-´ vidades antiparasitarias, Universidad de Antioquia, Antioquia, Colombia, 2016.
[185] P. Ciminiello, C. Dell’Aversano, E. Fattorusso,S . Magno, L. Carrano, and M. Pansini, “Chemistry of Verongida sponges. VII bromocompounds from the caribbean sponge Aplysina archeri,” Tetrahedron, vol. 52, no. 29, pp. 9863–9868, 1996.
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Advances in Virology, Vol 2021 (2021)
[1]
[2] UNAIDS, Global HIV & AIDS Statistics-2020 Fact Sheet, UNAIDS, Geneva, Switzerland, unaids.org2020, 2020.
[3]
[4] T. B. Ng, B. Huang, W. P. Fong, and H. W. Yeung, “Antihuman immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors,” Life Sciences, vol. 61, no. 10, pp. 933–949, 1997.
[5] Panel on Antiretroviral Guidelines for Adults and Adolescents, Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, Department of Health and Human Services, Washington, DC, USA, 2019.
[6] Organization WH, Guideline on when to Start Antiretroviral ?erapy and on Pre-exposure Prophylaxis for HIV, 78 pages, World Health Organization, Geneva, Switzerland, 2015.
[7] D. King,
[8] J. Stekler, J. Maenza, C. Stevens et al., “Abacavir hypersensitivity reaction in primary HIV infection,” Aids, vol. 20, no. 9, pp. 1269–1274, 2006.
[9] B.
[10] V. Montessori, N. Press, M. Harris, L. Akagi, and J.
[11]
[12] L. Menendez-Arias, “Targeting HIV: antiretroviral therapy ´ and development of drug resistance,” Trends in Pharmacological Sciences, vol. 23, no. 8, pp. 381–388, 2002.
[13] E. M. Gardner, W. J. Burman, J. F. Steiner, P. L. Anderson, and D. R. Bangsberg, “Antiretroviral medication adherence and the development of class-specific antiretroviral resistance,” AIDS, vol. 23, no. 9, pp. 1035–1046, 2009
[14] J. B. Nachega, V. C. Marconi, G. U. van Zyl et al., “HIV treatment adherence, drug resistance, virologic failure: evolving concepts,” Infectious Disorders Drug Targets, vol. 11, no. 2, pp. 167–174, 2011.
[15] P. Yeni, “Update on HAART in HIV,” Journal of Hepatology, vol. 44, 2006
[16] F. Nakagawa, A. Miners, C. J. Smith et al., “Projected lifetime healthcare costs associated with HIV infection,” PLoS One, vol. 10, no. 4, Article ID e0125018, 2015.
[17] N. E. +omford, D. A. Senthebane, A. Rowe et al., “Natural products for drug discovery in the 21st century: innovations for novel drug discovery,” International Journal of Molecular Sciences, vol. 19, no. 6, 2018.
[18] L. Palmisano and
[19] K. Vermani and
[20] D. Chattopadhyay, M. C. Sarkar, T. Chatterjee et al., “Recent advancements for the evaluation of anti-viral activities of natural products,” New Biotechnology, vol. 25, no. 5, pp. 347–368, 2009.
[21] K. Yazaki, G.-i. Arimura, and T. Ohnishi, “Hidden’ terpenoids in plants: their biosynthesis, localization and ecological roles,” Plant and Cell Physiology, vol. 58, no. 10, pp. 1615–1621, 2017
[22] D. +oll, “Biosynthesis and biological functions of terpenoids in plants,” Biotechnology of Isoprenoids, vol. 148, pp. 63–106, 2015.
[23] J.-H. Yu, G.-C. Wang, Y.-
[24] M. Shahidul Alam, M. A. Quader, and M. A. Rashid, “HIVinhibitory diterpenoid from Anisomeles indica,” Fitoterapia, vol. 71, no. 5, pp. 574–576, 2000.
[25]
[26]
[28] Y.-Y. Cheng, H. Chen, H.-P. He et al., “Anti-HIV active daphnane diterpenoids from Trigonostemon thyrsoideum,” Phytochemistry, vol. 96, pp. 360–369, 2013.
[29] T. Fujioka, Y. Kashiwada, R. E. Kilkuskie et al., “Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids,” Journal of Natural Products, vol. 57, no. 2, pp. 243–247, 1994.
[30] T. Kanamoto, Y. Kashiwada, K. Kanbara et al., “Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 4, pp. 1225–1230, 2001.
[31] F. Li, R. Goila-Gaur, K. Salzwedel et al., “PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing,” Proceedings of the National Academy of Sciences, vol. 100, no. 23, pp. 13555–13560, 2003.
[32] Y. Zhao, Q. Gu,
[33] F. Soler, C. Poujade, M. Evers et al., “Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry,” Journal of Medicinal Chemistry, vol. 39, no. 5, pp. 1069–1083, 1996.
[34] J. Tang,
[35] H.-X. Xu, F.-Q. Zeng, M. Wan, and K.-Y. Sim, “Anti-HIV triterpene acids fromGeum japonicum,” Journal of Natural Products, vol. 59, no. 7, pp. 643–645, 1996.
[36] Y. Kashiwada, T. Nagao, A. Hashimoto et al., “Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid Derivatives1,” Journal of Natural Products, vol. 63, no. 12, pp. 1619–1622, 2000
[37] N. Kongkum, P. Tuchinda, M. Pohmakotr et al., “Cytotoxic, antitopoisomerase IIα, and anti-HIV-1 activities of triterpenoids isolated from leaves and twigs of Gardenia carinata,” Journal of Natural Products, vol. 76, no. 4, pp. 530–537, 2013.
[38]
[39] B.-
[40] T. Konoshima, I. Yasuda, Y. Kashiwada, L. M. Cosentino, and K.-H. Lee, “Anti-AIDS agents, 21. Triterpenoid saponins as anti-HIV principles from fruits of gleditsia japonica and gymnocladus chinesis, and a structure-activity correlation,” Journal of Natural Products, vol. 58, no. 9, pp. 1372–1377, 1995.
[41] Y. Kashman, K. R. Gustafson, R. W. Fuller et al., “HIV inhibitory natural products. Part 7. +e calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum,” Journal of Medicinal Chemistry, vol. 35, no. 15, pp. 2735–2743, 1992.
[42] M. Huerta-Reyes, M. d. C. Basualdo, F. Abe, M. JimenezEstrada, C. Soler, and R. Reyes-Chilpa, “HIV-1 inhibitory compounds from Calophyllum brasiliense leaves,” Biological and Pharmaceutical Bulletin, vol. 27, no. 9, pp. 1471–1475, 2004
[43] A. D. Patil, A. J. Freyer, D.
[44] H. Dharmaratne, W. Wanigasekera, E. Mata-Greenwood, and J. Pezzuto, “Inhibition of human immunodeficiency virus type 1 reverse transcriptase activity by cordatolides isolated fromCalophyllum cordato-oblongum,” Planta Medica, vol. 64, no. 05, pp. 460-461, 1998.
[45] H. R. W. Dharmaratne, G. T. Tan, G. P. K. Marasinghe, and J. M. Pezzuto, “Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones,” Planta Medica, vol. 68, no. 1, pp. 86-87, 2002.
[46] E. Kudo, M. Taura, K. Matsuda et al., “Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 3, pp. 606–609, 2013.
[47] P. Zhou, Y. Takaishi, H. Duan et al., “Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release,” Phytochemistry, vol. 53, no. 6, pp. 689–697, 2000.
[48] N. Marquez, R. Sancho, L. M. Bedoya et al., “Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway,” Antiviral Research, vol. 66, no. 2-3, pp. 137–145, 2005.
[49] Q. Wang, Z. Ding, J. Liu, and Y. Zheng, “Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus,” Antiviral Research, vol. 64, no. 3, pp. 189–194, 2004.
[50] D. C. Rowley, M.
[51] N. Mahmood, C. Pizza, R. Aquino et al., “Inhibition of HIV infection by flavanoids,” Antiviral Research, vol. 22, no. 2-3, pp. 189–199, 1993.
[52]
[53] K. Kitamura, M. Honda, H. Yoshizaki et al., “Baicalin, an inhibitor of HIV-1 production in vitro,” Antiviral Research, vol. 37, no. 2, pp. 131–140, 1998.
[54] B. Q. Li, T. Fu, Y. Dongyan, J. A. Mikovits, F. W. Ruscetti, and J. M. Wang, “Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry,” Biochemical and Biophysical Research Communications, vol. 276, no. 2, pp. 534–538, 2000.
[55]
[56] P. Chaniad, C. Wattanapiromsakul,
[57] J. T. Ortega, A. I. Suarez, M. L. Serrano, J. Baptista, F. H. Pujol, and H. R. Rangel, “+e role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro,” AIDS Research and ?erapy, vol. 14, no. 1, 57 pages, 2017.
[58] A. Mazumder, K. Raghavan, J. Weinstein, K. W. Kohn, and Y. Pommier, “Inhibition of human immunodeficiency virus type-1 integrase by curcumin,” Biochemical Pharmacology, vol. 49, no. 8, pp. 1165–1170, 1995.
[59] A. Mazumder, N. Neamati,
[60] N. Kumari, A. A. Kulkarni, X. Lin et al., “Inhibition of HIV-1 by curcumin A, a novel curcumin analog,” Drug Design, Development and ?erapy, vol. 9, pp. 5051–5060, 2015.
[61] R. A. Reinke, D. J. Lee, B. R. McDougall et al., “L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro,” Virology, vol. 326, no. 2, pp. 203–219, 2004.
[62] Y.-J. Zou, H.-X. Wang, T.-B. Ng, C.-Y. Huang, and J.-X. Zhang, “Purification and characterization of a novel laccase from the edible mushroom Hericium coralloides,” ?e Journal of Microbiology, vol. 50, no. 1, pp. 72–78, 2012.
[63] H. X. Wang and T. B. Ng, “A new laccase from dried fruiting bodies of the monkey head mushroom Hericium erinaceum,” Biochemical and Biophysical Research Communications, vol. 322, no. 1, pp. 17–21, 2004.
[64] M. Li, G. Zhang, H. Wang, and T. Ng, “Purification and characterization of a laccase from the edible wild mushroom Tricholoma mongolicum,” Journal of Microbiology and Biotechnology, vol. 20, no. 7, pp. 1069–1076, 2010.
[65] H. X. Wang and T. B. Ng, “A laccase from the medicinal mushroom Ganoderma lucidum,” Applied Microbiology and Biotechnology, vol. 72, no. 3, pp. 508–513, 2006
[66] J. Sun, Q. J. Chen, Q. Q. Cao et al., “A laccase with antiproliferative and HIV-I reverse transcriptase inhibitory activities from the mycorrhizal fungus Agaricus placomyces,” Journal of Biomedicine & Biotechnology, vol. 2012, Article ID 736472, 12 pages, 2012.
[67] D. D. Hu, R. Y. Zhang, G. Q. Zhang, H. X. Wang, and T. B. Ng, “A laccase with antiproliferative activity against tumor cells from an edible mushroom, white common Agrocybe cylindracea,” Phytomedicine, vol. 18, no. 5, pp. 374–379, 2011
[68] H. X. Wang and T. B. Ng, “Purification of a novel lowmolecular-mass laccase with HIV-1 reverse transcriptase inhibitory activity from the mushroom Tricholoma giganteum,” Biochemical and Biophysical Research Communications, vol. 315, no. 2, pp. 450–454, 2004.
[69]
[70] X. Wu, C. Huang, Q. Chen, H. Wang, and J. Zhang, “A novel laccase with inhibitory activity towards HIV-I reverse transcriptase and antiproliferative effects on tumor cells from the fermentation broth of mushroomPleurotus cornucopiae,” Biomedical Chromatography, vol. 28, no. 4, pp. 548–553, 2014.
[71] J. H. Wong, T. B. Ng, Y. Jiang, F. Liu,
[72] G.-Q. Zhang, Y.-F. Wang, X.-Q. Zhang, T. B. Ng, and H.-X. Wang, “Purification and characterization of a novel laccase from the edible mushroom Clitocybe maxima,” Process Biochemistry, vol. 45, no. 5, pp. 627–633, 2010.
[73] L. Xu, H. Wang, and T. Ng, “A laccase with HIV-1 reverse transcriptase inhibitory activity from the broth of mycelial culture of the mushroom Lentinus tigrinus,” BioMed Research International, vol. 2012, Article ID 536725, 7 pages, 2012.
[74] J. Sun, H. Wang, and T. B. Ng, “Isolation of a laccase with HIV-1 reverse transcriptase inhibitory activity from fresh fruiting bodies of the Lentinus edodes (Shiitake mushroom),” Indian Journal of Biochemistry & Biophysics, vol. 48, no. 2, pp. 88–94, 2011.
[75] H. X. Wang and T. B. Ng, “Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases,” Planta Medica, vol. 67, no. 7, pp. 669–672, 2001.
[76] J. Balzarini, D. Schols, J. Neyts, E. Van Damme, W. Peumans, and E. De Clercq, “Alpha-(1-3)-and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro,” Antimicrobial Agents and Chemotherapy, vol. 35, no. 3, pp. 410–416, 1991.
[77] J. Balzarini, J. Neyts, D. Schols et al., “+e mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro,” Antiviral Research, vol. 18, no. 2, pp. 191–207, 1992.
[78] R. D. Charan, M. H. G. Munro, B. R. O’Keefe et al., “Isolation and characterization ofMyrianthus holstiiLectin, a potent HIV-1 inhibitory protein from the PlantMyrianthus holstii1,” Journal of Natural Products, vol. 63, no. 8, pp. 1170–1174, 2000
[79] G. Ferir, D. Huskens,
[80] T. Mori, B. R. O’Keefe, R. C. Sowder 2nd. et al., “Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp,” Journal of Biological Chemistry, vol. 280, no. 10, pp. 9345–9353, 2005.
[81]
[82] Y. R. Li, Q. H. Liu, H. X. Wang, and T. B. Ng, “A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus,” Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1780, no. 1, pp. 51–57, 2008.
[83] C. H. Han, Q. H. Liu, T. B. Ng, and H. X. Wang, “A novel homodimeric lactose-binding lectin from the edible split gill medicinal mushroom Schizophyllum commune,” Biochemical and Biophysical Research Communications, vol. 336, no. 1, pp. 252–257, 2005.
[84] G. Q. Zhang, J. Sun, H. X. Wang, and T. B. Ng, “A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa,” Acta Biochimica Polonica, vol. 56, no. 3, pp. 415–421, 2009.
[85] J. K. Zhao, H. X. Wang, and T. B. Ng, “Purification and characterization of a novel lectin from the toxic wild mushroom Inocybe umbrinella,” Toxicon, vol. 53, no. 3, pp. 360–366, 2009.
[86]
[87] Y. Li, G. Zhang, T. B. Ng, and H. Wang, “A novel lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from dried fruiting bodies of the monkey head mushroom Hericium erinaceum,” BioMed Research International, vol. 2010, Article ID 716515, 9 pages, 2010.
[88] H. Wang and T. B. Ng, “Isolation and characterization of velutin, a novel low-molecular-weight ribosome-inactivating protein from winter mushroom (Flammulina velutipes) fruiting bodies,” Life Sciences, vol. 68, no. 18, pp. 2151–2158, 2001.
[89]
[90]
[91] J. H. Wong, H. X. Wang, and T. B. Ng, “Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus,” Applied Microbiology and Biotechnology, vol. 81, no. 4, pp. 669–674, 2008
[92] Y.-M. Ng, Y. Yang, K.-H. Sze, X. Zhang, Y.-T. Zheng, and P.-C. Shaw, “Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindrica),” Journal of Structural Biology, vol. 174, no. 1, pp. 164–172, 2011.
[93] I. Kaur, M. Puri, Z. Ahmed, F. P. Blanchet, B. Mangeat, and V. Piguet, “Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina,” PLoS One, vol. 8, no. 9, Article ID e73780, 2013.
[94] F. Rajamohan, T. K. Venkatachalam, J. D. Irvin, and F. M. Uckun, “Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1,” Biochemical and Biophysical Research Communications, vol. 260, no. 2, pp. 453–458, 1999.
[95] T. Ichiba, P. J. Scheuer, M. Kelly-borges, and F. Pierce, “+ree bromotyrosine derivatives, one terminating in an unprecedented diketocyclopentenylidene enamine,” ?e Journal of Organic Chemistry, vol. 58, no. 15, pp. 4149-4150, 1993.
[96] D. Gochfeld, K. El Sayed, M. Yousaf et al., “Marine natural products as lead anti-HIV agents,” Mini-Reviews in Medicinal Chemistry, vol. 3, no. 5, pp. 401–424, 2003.
[97] L. G. G´omez-Archila, W. Zapata, F. J. D´ıaz, M. T. Rugeles, E. Galeano, and A. Mart´ınez, “Bromotyrosine derivatives from marine sponges inhibit the HIV-1 replication in vitro,” Vitae, vol. 21, no. 2, pp. 114–125, 2014
[98]
[99] P. Yogeeswari and D. Sriram, “Betulinic acid and its derivatives: a review on their biological properties,” Current Medicinal Chemistry, vol. 12, no. 6, pp. 657–666, 2005.
[100] D. E. Martin, R. Blum, J. Wilton et al., “Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 9, pp. 3063–3066, 2007.
[101] D. E. Martin, R. Blum, J. Doto, H. Galbraith, and C. Ballow, “Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV Maturation, in healthy volunteers,” Clinical Pharmacokinetics, vol. 46, no. 7, pp. 589–598, 2007.
[102] P. F. Smith, A. Ogundele, A. Forrest et al., “Phase I and II study of the safety, virologic effect, and pharmacokinetics/ pharmacodynamics of single-dose 3-O-(3′,3′-Dimethylsuccinyl)Betulinic acid (bevirimat) against human immunodeficiency virus infection,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 10, pp. 3574–3581, 2007.
[103] N. A. Margot, C.
[104] A. Neyret, B. Gay, A. Cransac et al., “Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation,” Antiviral Research, vol. 164, pp. 162–175, 2019.
[105] B. Labrosse, O. Pleskoff, N. Sol, C. Jones, Y. H´enin, and M. Alizon, “Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41,” Journal of Virology, vol. 71, no. 11, pp. 8230–8236, 1997.
[106] B. Labrosse, C. Treboute, and M. Alizon, “Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region,” Journal of Virology, vol. 74, no. 5, pp. 2142–2150, 2000.
[107] I. Kostova,
[108] B. Chenera, M. L. West, J. A. Finkelstein, and G. B. Dreyer’, “Total synthesis of (±)-calanolide A, a non-nucleoside inhibitor of HIV-1 reverse transcriptase,” ?e Journal of Organic Chemistry, vol. 58, no. 21, 1993.
[109] A. Kucherenko, M. T. Flavin, W. A. Boulanger et al., “Novel approach for synthesis of (±)-calanolide a and its anti-HIV activity,” Tetrahedron Letters, vol. 36, no. 31, 1995.
[110] M. T. Flavin, “Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (±)-Calanolide A and its enantiomers,” Journal of Medicinal Chemistry, vol. 39, no. 6, 1995
[111] J. H. Cardellina, H. R. Bokesch, T. C. McKee, and M. R. Boyd, “Resolution and comparative anti-HIV evaluation of the enantiomers of calanolides A and B,” Bioorganic & Medicinal Chemistry Letters, vol. 5, no. 9, pp. 1011–1014, 1995
[112] R. W. Buckheit Jr., E. L. White, V. Fliakas-Boltz et al., “Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 8, pp. 1827–1834, 1999
[113] R. Buckheit Jr., V. Fliakasboltz, W. Decker et al., “Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups,” Antiviral Research, vol. 26, no. 2, pp. 117–132, 1995.
[114] J. C. Garc´ıa Zebad´ua, G. A. Magos Guerrero, M. Mumbr´u Massip et al., “Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico,” Fitoterapia, vol. 82, no. 7, pp. 1027–1034, 2011.
[115] T. Creagh, J. L. Ruckle, D. T. Tolbert et al., “Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 5, pp. 1379–1386, 2001.
[116] D. A. Eiznhamer, T. Creagh, J. L. Ruckle et al., “Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers,” HIV Clinical Trials, vol. 3, no. 6, pp. 435–450, 2002.
[117] K. Matsuda,
[118] H. Wang, Y. Liu, C. Huan et al., “NF-κB-Interacting long noncoding RNA regulates HIV-1 replication and latency by repressing NF-κB signaling,” Journal of Virology, vol. 94, no. 17, 2020.
[119] P. Bremner and M. Heinrich, “Natural products as targeted modulators of the nuclear factor-kappaB pathway,” ?e Journal of Pharmacy and Pharmacology, vol. 54, no. 4, pp. 453–472, 2002.
[120] M. Karin, Y. Yamamoto, and Q. M. Wang, “+e IKK NF-κB system: a treasure trove for drug development,” Nature Reviews Drug Discovery, vol. 3, no. 1, pp. 17–26, 2004.
[121] R. Sancho, N. Marquez, M. G ´ omez-Gonzalo et al., ´ “Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway,” Journal of Biological Chemistry, vol. 279, no. 36, pp. 37349–37359, 2004.
[122] E. Kozioł and K. Skalicka-Woz´niak, “Imperatorin–pharmacological meaning and analytical clues: profound investigation,” Phytochemistry Review, vol. 15, pp. 627–649, 2016.
[123] M. Deng, L. Xie, L. Zhong, Y. Liao, L. Liu, and X. Li, “Imperatorin: a review of its pharmacology, toxicity and pharmacokinetics,” European Journal of Pharmacology, vol. 879, 2020.
[124] G. Casano, A. Dum`etre, C. Pannecouque,
[125] T. P. T. Cushnie and A. J. Lamb, “Antimicrobial activity of flavonoids,” International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 343–356, 2005.
[126] X. Zhao, K. Jiang, B. Liang, and X. Huang, “Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway,” Oncology Reports, vol. 35, no. 2, pp. 669–675, 2016.
[127] B. W. Vanhoecke, F. Delporte, E. Van Braeckel et al., “A safety study of oral tangeretin and xanthohumol administration to laboratory mice,” Vivo, vol. 19, no. 1, pp. 103–107, 2005.
[128] K. Yamaguchi, M. Honda, H. Ikigai, Y. Hara, and T. Shimamura, “Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1),” Antiviral Research, vol. 53, no. 1, pp. 19–34, 2002.
[129] K. Kawai, N. H. Tsuno, J. Kitayama et al., “Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding,” Journal of Allergy and Clinical Immunology, vol. 112, no. 5, pp. 951–957, 2003.
[130] C. L. Nance, E. B. Siwak, and W. T. Shearer, “Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy,” Journal of Allergy and Clinical Immunology, vol. 123, no. 2, pp. 459–465, 2009.
[131] P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, “Bioavailability of curcumin: problems and promises,” Molecular Pharmaceutics, vol. 4, no. 6, pp. 807–818, 2007.
[132] C. J. Li, L. J. Zhang, B. J. Dezube, C.
[133] A. Ali and A. C. Banerjea, “Curcumin inhibits HIV-1 by promoting Tat protein degradation,” Scientific Reports, vol. 627539 pages, 2016.
[134] A. L. Cheng, C. H. Hsu, J. K. Lin et al., “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with highrisk or pre-malignant lesions,” Anticancer Research, vol. 21, no. 4b, pp. 2895–2900, 2001.
[135] G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. Srinivas, “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers,” Planta Medica, vol. 64, no. 4, pp. 353–356, 1998.
[136] P. Baldrian, “Fungal laccases-occurrence and properties,” FEMS Microbiology Reviews, vol. 30, no. 2, pp. 215–242, 2006.
[137] P. Giardina, V. Faraco, C. Pezzella, A. Piscitelli,
[138] M. Bottcher and F. Grosse, “HIV-1 protease inhibits its ¨ homologous reverse transcriptase by protein-protein interaction,” Nucleic Acids Research, vol. 25, pp. 1709–1714, 1997
[139] T. B. Ng and H. X. Wang, “A homodimeric laccase with unique characteristics from the yellow mushroom Cantharellus cibarius,” Biochemical and Biophysical Research Communications, vol. 313, no. 1, pp. 37–41, 2004.
[140] H. X. Wang and T. B. Ng, “A novel laccase with fair thermostability from the edible wild mushroom (Albatrella dispansus),” Biochemical and Biophysical Research Communications, vol. 319, no. 2, pp. 381–385, 2004.
[141] A. E. Franco Molano and E. Uribe-Calle, “Hongos agricales y boletales de Colombia,” Biota Colombiana, vol. 1, no. 1, pp. 25–43, 2000.
[142] C. Arboleda, A. I. Mej´ıa, A. E. Franco-Molano, G. A. Jim´enez, and J. Pm, “Autochthonous white rot fungi from the tropical forest of Colombia for dye decolourisation and ligninolytic enzymes production,” Sydowia, vol. 60, no. 2, pp. 165–180, 2008.
[143] A. Ruiz and A. Varela, “Nuevos registros de Aphyllophorales (Basidiomicota) en bosque montano h´umedo y de niebla de Colombia,” Caldasia, vol. 28, no. 2, pp. 259–266, 2006.
[144] L. Florez-sampedro, W. Zapata, W. Zapata et al., “In vitro ´ anti-HIV-1 activity of the enzymatic extract enriched with laccase produced by the fungi ganoderma sp. and lentinus sp,” Revista Vitae, vol. 23, no. 2, pp. 109–118, 2016.
[145] R. Goldstein Ijh, M. Monsigny, T. Osawa, and N. Sharon, “What should be called a lectin?” Nature, vol. 285, no. 66, 1980.
[146] H. Wang, T. B. Ng, and V. E. C. Ooi, “Lectins from mushrooms,” Mycological Research, vol. 102, no. 8, pp. 897–906, 1998.
[147] J. Guillot and G. Konska, “Lectins in higher fungi,” Biochemical Systematics and Ecology, vol. 25, no. 3, pp. 203–230, 1997.
[148] H. X. Wang, T. B. Ng, W. K. Liu, V. E. Ooi, and
[149] P. H. K. Ngai and T. B. Ng, “Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells,” Life Sciences, vol. 73, no. 26, pp. 3363–3374, 2003.
[150] H. Wang, T. B. Ng, and Q. Liu, “Isolation of a new heterodimeric lectin with mitogenic activity from fruiting bodies of the mushroom Agrocybe cyli
[151] Q.-B. She, T.-B. Ng, and W.-K. Liu, “A novel lectin with potent immunomodulatory activity isolated from both fruiting bodies and cultured mycelia of the edible MushroomVolvariella volvacea,” Biochemical and Biophysical Research Communications, vol. 247, no. 1, pp. 106–111, 1998
[152]
[153]
[154] T.-
[155] M. D. Swanson, H. C. Winter, I. J. Goldstein, and D. M. Markovitz, “A lectin isolated from bananas is a potent inhibitor of HIV replication,” Journal of Biological Chemistry, vol. 285, no. 12, pp. 8646–8655, 2010.
[156] T. Mori, B. R. O’Keefe, R. C. Sowder 2nd. et al., “Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp,” Journal of Biological Chemistry, vol. 280, no. 10, pp. 9345–9353, 2004.
[157] K. B. Alexandre, E.
[158] P. Emau, B. Tian, B. R. O’keefe et al., “Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide,” Journal of Medical Primatology, vol. 36, no. 4-5, pp. 244–253, 2007.
[159] B. R. O’Keefe, F. Vojdani, V. Buffa et al., “Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component,” Proceedings of the National Academy of Sciences, vol. 106, no. 15, pp. 6099–6104, 2009
[160] J. C. Kouokam, D. Huskens, D. Schols et al., “Investigation of griffithsin’
[161] C. Barton, J. C. Kouokam, A. B. Lasnik et al., “Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 1, pp. 120–127, 2014.
[162] G. Ferir, K. E. Palmer, and D. Schols, “Synergistic activity ´ profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C,” Virology, vol. 417, no. 2, pp. 253–258, 2011.
[163] L. F. Kramzer, K. T. Hamorsky, P. W. Graebing et al., “Preformulation characterization of griffithsin, a biopharmaceutical candidate for HIV prevention,” AAPS PharmSciTech, vol. 22, no. 3, 83 pages, 2021.
[164] G. G¨unaydın, G. Edfeldt, D. A. Garber et al., “Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: in situ analyses of epithelial and immune cell markers in rectal mucosa,” Scientific Reports, vol. 9, no.1, 18120 pages, 2019.
[165] K. R. Crakes, C. Herrera, J. L. Morgan et al., “Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo,” Journal of the International AIDS Society, vol. 23, no. 10, Article ID e25628, 2020.
[166] F. Minooei, J. R. Fried, J. L. Fuqua, K. E. Palmer, and J. M. Steinbach-Rankins, “In vitro study on synergistic interactions between free and encapsulated Q-griffithsin and antiretrovirals against HIV-1 infection,” International Journal of Nanomedicine, vol. 16, pp. 1189–1206, 2021
[167] “Study to evaluate the safety of griffithsin in a carrageenan gel in healthy women clinicaltrials,” 2021, https://clinicaltrials. gov/ct2/show/study/NCT02875119.
[168] “Griffithsin-based rectal microbicide for PREvention of viral ENTry,” 2021, https://clinicaltrials.gov/ct2/show/ NCT04032717
[169] R. A. Collins, T. B. Ng, W. P. Fong, C. C. Wan, and H. W. Yeung, “A comparison of human immunodeficiency virus type 1 inhibition by partially purified aqueous extracts of Chinese medicinal herbs,” Life Sciences, vol. 60, no. 23, pp. Pl345–PL351, 1997.
[170] Q.-Z. Yao, M. M. Yu, L.
[171] T. Girbes, J. Ferreras, F. Arias, and F. Stirpe, “Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria,” Mini-Reviews in Medicinal Chemistry, vol. 4, no. 5, pp. 461–476, 2004
[172]
[173] P.-C. Shaw, K.-M. Lee, and K.-B. Wong, “Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties,” Toxicon, vol. 45, no. 6, pp. 683–689, 2005
[174] M.
[175] Y.-Y. Wang, D.-Y. Ouyang, H. Huang, H. Chan,
[176] W.-L. Zhao, D. Feng, J. Wu, and
[177] W. Zhao, D. Feng,
[178] V. Byers, A. Levin, L. Waites et al., “A phase I/II study of trichostathin treatment of HIV desease,” Current Science, vol. 4, no. 2, pp. 1189–1196, 1990.
[179] V.
[180] J. O. Kahn, K. J. Gorelick, G. Gatti et al., “Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 2, pp. 260–267, 1994.
[181] J. M. Zarling, P. A. Moran, O. Haffar et al., “Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies,” Nature, vol. 347, no. 6288, pp. 92–95, 1990.
[182] J. M. Zarling, P. A. Moran, O. Haffar et al., “Inhibition of HIV-1 replication in seropositive patients’ CD4+ T-cells by pokeweed antiviral protein-monoclonal antibody conjugates,” International Journal of Immunopharmacology, vol. 13, no. 1, pp. 63–68, 1991.
[183] G. Krivdova and K. A. Hudak, “Pokeweed antiviral protein restores levels of cellular APOBEC3G during HIV-1 infection by depurinating Vif mRNA,” Antiviral Research, vol. 122, pp. 51–54, 2015.
[184] M. H. Pastrana Restrepo,
[185] P. Ciminiello, C. Dell’Aversano, E. Fattorusso,
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Book
Martinez Costa, Brandon Smith; Valencia Castillo, Natalia; Veléz Duran, Yoly Mileidy; Jurado Rosero, Javier; Flórez Pardo, Luz Marina; Ariza Perez, Neddy Finrley; Barajas-Solano, Andrés Fernando; García-Martínez, Janet Bibiana; Rubio Fernández, Diego; Morales Granados, Miguel; Sandoval Herrera, Juan; Mahnert, Camilo; Oliva, Ignacio; Razeto, Renso; Cuenca-Quicazán, Martha; Restrepo-Serna, D. L; Cacua-Silva, A; Vejar-Gereda, A. G.; Corredor-Acuña, J.; Cortés, Jimmy; Meyer, Eduardo; Galvis Camperos, Olga Michelle; Urbina Suarez, Nestor Andrés; Leal Pérez, Gina Gabriela; Rojas Márquez, Astrid Melissa; López-Barrera, German Luciano; Bohórquez Barrera, Andrea Carolina; López Giraldo, Luis Javier; Benavides Martín, María Angélica; Narváez Rincón, Paulo César; Carvajal Albarracín, Nicolaz Alejandro; Kafarov, Viatcheslav; Martínez, Ana María; Sánchez Tobos, Leidy Paola; Barajas-Ferreira, Crisóstomo; Contreras-Ropero, Jefferson Eduardo; Leal Jerez, Ángela Gisselle; Moisés David, Duarte Rodríguez; Morales Rivas, Leidy Katherine; Garavito, Johanna; Brugés, Adler; Ramírez, Adrián M.; Yaya-González, Adrián; Herrera, Adriana; Rodríguez D., Adriana L.; Rodríguez Lizcano, Adriana; Suárez, Adriana; Jenny, Aguirre; Villa, Aída Luz; Giraldo Molina, Alba Nubia; Tafur Rangel, Albert Enrique; Albis, Alberto; Tovar Zapata, Aldair; Martínez, Aldemar; Cacua, Alejandra; Luna, Alejandra; Arango, Alejandra M.; Acosta‑Cárdenas, Alejandro; Gutiérrez, Alejandro; Molina, Alejandro; Reyes Muñoz, Alejandro; Saenz Castaño, Alejandro; Serrano, Alejandro; López- Córdoba, Alex; Cafiel, Alianys; Pataquiva-Mateus, Alis; Gonzales Mancera, Alix; Gómez, Álvaro; Malo, Alvaro; Orjuela Londoño, Álvaro; Villar, Álvaro; Bello, Ana; Ramos Murillo, Ana Isabel; López Villamizar, Ana María; Arias Pedraza, Ana Milena; Becerra Quiroz, Ana Paola; Correa, Ana Ruby; Galvis González, Anderson; González-Córdoba, Andrea; Tamayo Londoño, Andrea; Ramírez, Andrés Camilo; Castaño, Andrés; Ceballos, Andres; Suárez, Andrés F.; Ardila Gómez, Andrés Felipe; Soto Cuellar, Andrés Felipe; Suarez Escobar, Andrés Felipe; Vásquez, Andrés Felipe; González Barrios, Andrés Fernando; García Brand, Andrés; González Barrios, Andrés; Hurtado, Andrés; López Rojas, Andrés; Negrete Palacio, Andrés; Suarez, Andrés; Vargas, Andrés; Rodríguez, Angee; González Delgado, Ángel Darío; Villabona Ortíz, Angel; Cajiao, Ángela; Montoya, Angela; Ruíz-Colorado, Angela; Angarita, Angélica; Bonfante, Angelith; Rodríguez Bohórquez, Angie Dayana; Sinning-Mangonez, Angie; Salguero, Angie Viviana; Cadena, Ariel O.; Chaves-Guerrero, Arlex; Espinosa, Armando; Martínez, Arnaldo; Acevedo Rodríguez, Astrid Zuleima; Moreno M., Azarías; Camacho Rodríguez, Bernardo; Stambuk, Boris U.; Rincón-Sánchez, Brahian; Garzón Vargas, Brayan Esteban; Mónica, Cala; Gómez-Jaramillo, Camila; Franco, Camilo A.; Pardo Castaño, Camilo; Rodríguez, Camilo; Tejada Tovar, Candelaria; Alvarez, Carlos A.; Riascos, Carlos A. M.; Camargo Vila, Carlos Alfredo; Castellon, Carlos; Grande Tovar, Carlos David; Domínguez, Carlos; Granda-Ramírez, Carlos Fidel; Herrera, Carlos; Muvdi-Nova, Carlos Jesús; Jiménez, Carlos; Arrieta-Hurtado, Carlos M.; Angulo Zarate, Carlos Mauricio; Montenegro, Carlos; Rengifo, Carlos; Quintero-Pimiento, Carmen Rosa; Espinosa-Lobo, Carol B.; Hernández, Carola; Medina-Jaramillo, Carolina; Niebles, Carolina; Orozco, Carolina; Giraldo-Estrada, Catalina; Gonzales Villegas, Catherine; Rodríguez Diocelina, Celis; Isaza Roldan, Cesar Alejandro; Simancas Castilla, Cesar Augusto; García, Cesar; María, Chica; Hasenstab, Christian; Arenas, Cindy; Rozo Correa, Ciro E.; Hernández-Londoño, Claudia; Valderrama Rios, Claudia M.; Chaves-Lopez, Clemencia; Ricaurte Pérez, Cristian Alejandro; Celis, Cristian; Sanjuan, Cristian; Cruz, Juan C.; Cruz Reina, Luis J.; Granados., D.; Restrepo, Daissy; Rojano-Quiroz, Dalgido; Barbosa, Dalje; Borrás, Daniel; Builes, Daniel H.; López, Daniel; Marín, Daniel; Rojas Méndez, Daniel; Rozo, Daniel; Alvarado-Barrios, Daniela; Bernal, Daniela M.; Ortega-Villamizar, Daniela; Parra, Daniela; Cubides Maldonado, David Alejandro; Munar Segura, David Andrés; Coral, David; Echeverri, David; González Sánchez, David; Madroñero, David; Martin, David; Orjuela Yepes, David; Patiño Ruiz, David; Castillo Vasco, Dayanna; Plata Cabarique, Dayanne Luz; Alcida Nabarlatz, Débora; Arango Trujillo, Deibinson; Guzmán S, Diana K; Grajales, Diana L; Cañas-Martínez, Diana M.; Moncayo Martínez, Diana; Ostos, Diana; Rodríguez, Didier; Peña-Villamizar, Diego A.; Castellanos, Diego Alberto; Feo, Diego Alejandro; Torres Giraldo, Diego Alejandro; Montenegro Apraez, Diego Armando; Barbosa, Diego; Henao, Diego; Rojas, Diego; Romero, Diego; Santos, Diego; Carmona, Dora M.; Becerra Moreno, Dorance; Monsalve Londoño, Doris Jackeline; Abril, Duvan; Coronell, Edgar A.; Mayorga, Edgar; Morales, Edgar; Oviedo, Edgar; Quiñones-Bolaños, Edgar; Murillo, Eduard; Sanchez-Galvis, Edwar Mauricio; Herrera, Edward; Arenas Calderon, Edward J.; Alarcón, Edwin Alexis; Martínez-Arcia, Edwin; Sánchez, Edwin; Velasco-Rozo, Edwing A.; Coronado, Eileen K.; Peñaranda Lizarazo, Elena Maria; Alhadef, Eliana; Diaz, Eliana; Rodríguez Carreño, Elizabeth; Naranjo Estepa, Elma Bibiam; Ariza León, Emiliano; González, Eric David; Vera, Erik; Ortiz, Erika Y.; Restrepo, Esteban; Sánchez Castelblanco, Etna Milena; Orozco Cera, Eusebio José; Jiménez-Rojas, Evelyn; Chejne, F.; Aguirre T., Fabian A.; Aguilar Bermudez, Fabián; Pájaro Moreno, Yeraldin; Navarro, Fabian; Cortés, Farid B.; Alvarado, Felipe; Correa, Felipe; Salcedo Galán, Felipe; Vargas Torres, Felipe; Castillo, Ferley; Fernández-Niño, Miguel; Díaz-Acosta, Fernando; Bertel, Forlin; Toscano, Francis; Buitrago-Flórez, Francisco; López, Franz; Ramos Rodríguez, Freddy Alejandro; Avellaneda Vargas, Fredy Augusto; Chanchí Golondrino, Gabriel; Vejar, Gabriela; Riaño, George; Gómez, Geraldyne; Rodríguez, Gerardo; Castro Moreno, Germán Andrés; De Avila Montiel, Gezira; Hincapié-Mejía, Gina; Lezama, Gina; Barragan, Ginna; Vergel, Giovanni; Cardenas Calvachi, Gloria Lucia; Metha, Gregory F.; Cogollo, Grisel; Vega, Guillermo; Bolaños, Gustavo; Ramírez-Caballero, Gustavo E.; Orozco, Gustavo; Salguero López, Gustavo; Herees, H. J.; Carrillo, Hamilton; Berdugo, Héctor; Chacón, Héctor; Olarte, Hector Hugo; León Merchán, Heinny Estefanía; Quintero, Henderson; Fabio, Herrera; Soto, Hesneider; Ramirez Malule, Howard; Calderon, Hugo; Galindo, Hugo; Gomajoa, Hugo; Olarte, Hugo; Zea Ramírez, Hugo Ricardo; Bonilla Mancilla, Humberto; Escalante, Humberto; Rodríguez, Ignacio; Baldiris-Navarro, Ildefonso; Silva Cote, Ingrid Zulay; Pardo Mendoza, Ingrit Daniela; Salgado Escobar, Irma; Mejía, Isabel; Ortiz C., Iván A.; Cabeza, Ivan; Suárez-Acelas, Iván E.; Gil, Iván; Mora, Iván; Dobrosz-Gómez, Izabela; Quintero, J. David; Pacheco, J.; Jaimes-Estevez, J.; Osorio, J.; Beltrán M., J. J.; Ramón, Jacipt; Gallo-Machado, Jacobo; Corredor Acuña, Jacqueline; Arturo, Jaime; Velasco-Medina, Jaime; Becerra, Jaime-Andrés; Moncada Ortíz, Jairo Andrés; Perilla, Jairo E.; Martínez-Consuegra, Jairo; Arroyo León, Jaison Daniel; Leones, Jalelys; Marín Gómez, James Alberto; Yandar, Jasson; Dávila, Javier; Ilarri, Javier Rodrigo; Magnin, Jean P.; Castillo, Jefferson; León-Pulido, Jeffrey; Gracia Rojas, Jeniffer Paola; Piragua, Jenny Carolina; del Pino, Jenny; Tirado Solano, Jessenia Yulieth; Contreras, Jessica; Hernandez, Jessica M.; Velandia, Jessica; Guerra, Jesús; Morales García, Jesus; Mosquera, Jhessica; Quinter, Jhon; Osma, Johann F.; Herrera, Johanna; Solano Meza, Johanna Karina; Castañeda, Jonathan; Aranda Caraballo, Jorge; Castillo Olaya, Jorge; Duitama Castellanos, Jorge; López Macías, Jorge Nelson; Sanchez, Jorge; Abril M, Jormagn I.; Martínez Sepúlveda, José Alejandro; Segura Flórez, José Andrés; Henao, José Antonio; Escobar, José Carlos; Bejarano, José Felipe; Mendoza Abella, José Felipe; Ramírez Franco, José Herney; López Genes, José; Hernández Chinchilla, Josué; Acosta, Juan; Burgos, Juan C.; González-Téllez, Juan C.; Molano, Juan C.; Ortiz, Miguel F.; Serrato Bermúdez, Juan C.; Herrera, Juan Camilo; Gómez-Daza, Juan Carlos; Serrato Bermúdez, Juan Carlos; Castañeda, Juan; Martínez, Juan Daniel; Tabares Hurtado, Juan David; Jaramillo, Juan; Romero, Juan José; Anzola, Juan Manuel; Heredia Martín, Juan Pablo; Ramírez, Juan; Rivera-Díaz, Juan; Romero-Pérez, Juan; Amaya Cano, Juan Sebastian; Guerrero Pérez, Juan Sebastián; Rodríguez Flórez, Juan Sebastián; Wilches, Juan; Acosta, Julian; Munera, Julián; Ávila-Ortiz, Juliana; Puello Méndez, Juliana; García, Julieth; Vargas, Julio; Martínez Marciales, Karen Piedad; Moreno-Sader, Kariana; Ojeda Delgado, Karina; Beltrán Ricaute, Karl Michael; Benavides, Katherine; Fernández, Katherine; Pacheco, Keiry Alejandra; Betancur, Kelly; Cogollo Pabón, Kelly Johana; Zuluaga, Kelly; Pérez, Kevin D.; Medina, L.; Giraldo, Lady; Rehmann, Lars; Bueno M., Laura A.; Conde, Laura; Ramírez-Rodríguez, Laura Cristina; Parra Daza, Laura Estefanía; Moreno, Laura; Plazas Tovar, Laura; Conde, Laura R.; Vargas, Laura; Arango León, Laura Victoria; Pernett, Leda; Real Salas, Leidy Dayana; Avila P., Leidy T.; Vergara-Echeverry, Leidy; León, Leinis; de la Rosa, Lenis; Rubiano, Leonardo; Sánchez Castillo, Leslie Vanessa; Rodríguez, Lesly; Tejeda- Benítez, Lesly; León, Lexy; Mora-Vergara, Lia Z.; Mesa Ruiz, Lida Marcela; Rojas-Pérez, Lilia Carolina; Ávila Martín, Liliana; Castro, Liliana; Castañeda, Lina; Higuita, Lina; Castro Huari, Lina Juliana; González, Lina María; Montoya, Lina; Suárez Medina, Lina; Mallarino-Miranda, Liset; Garcia, Lizeth; Meriño, Lourdes; Rios, Luis Alberto; Gallego Villada, Luis Alfonso; Cobo Campo, Luis Armando; Córdoba, Luis; Sierra López, Luis David; Diaz-Montes, Luis; Jaimes, Luis G.; Gallego Villada, Luis; Martínez Orozco, Luis Jesús; López, Luis; Tejada, Luis Neil; Ríos Basto, Luz Daniela; Marín-Palacio, Luz Deisy; García, Luz Katerine; Ramos-Torres, Luz M.; Contreras-Mateus, M. Daniela; Rojas, M.; Figueredo, Manuel; Valero, Manuel; Marino, Marcos F.; Patiño, Margareth; Baia, María Alejandra; Morales, María Alejandra; Vásquez-Tuberquia, Maria Alejandra; Angarita Rangel, María Angélica; Legarda Zúñiga, María Angélica; Sarubbi Cabrera, María Belén; Solorzano, Maria C.; Suárez Gámez, María Camila; Penayo Ortellado, Maria Cristina; Taboada, María de los Ángeles; Pájaro, María Elvira; Altamiranda Anaya, Maria Fernanda; López Sierra, Maria Fernanda; Hernández Carrión, María; Rangel Hernández, Maria Isabel; Jaramillo, María; Chica, María José; Rodríguez Cubillos, María Juliana; Martínez, María; Acevedo Estupiñán, María Victoria; Quintanilla-Carvajal, María Ximena; Tejada Prieto, Mariana; Betancur, Mariluz; Jurado Eraso, Mario A.; Alvarez Cifuentes, Mario; Alvear Alayon, Mario; Llano Restrepo, Mario Andrés; Noriega, Mario Andrés; Velásquez, Mario; Quicazán, Marta Cecilia; Cepeda, Martha; Cervantes Díaz, Martha; Cobo, Martha I.; Tapia, Mary Judith Arias; Monguí, Mauricio; Cabarcas, Mauricio R.; Wagner, Maya G.; Mehrvar, Mehrab; Lara, Melissa; Vargas, Melissa; Durán, Melvin Aroldo; Vera, Mercedes; Hernández-Maya, Mery S.; Lozano, Michael; Fernández Niño, Miguel Ángel; Pinedo Alfonso, Miguel Angel; Castellanos Estupiñan, Miguel Ángel; Rondón, Miguel; Gómez, Miguel-Ángel; Toro Santos, Mischel Stefany; Andrade, Mónica; Jesús, Morales; Muñoz, Laura N.; Muñoz-Camargo, Carolina; Serrato, N. E. S.; González González, Nancy C.; Rodríguez Salamanca, Narella; Afanasjeva, Natalia; Cano, Natalia; Larios, Natalia; Moreno-Rubio, Nataly; Mantilla, Neila; Briceño, Nelson; Caicedo, Nelson H.; Piñeros-Guerrero, Nicolás; Puentes, Nicolás; Navarro Simancas, Nicolás Santiago; Velasquez, Nicolle; Gómez-Mesa, Nikolay; Castillo, Nilson; Porras Holguín, Niyireth Alicia; Pájaro Gómez, Nórida; Becerra, Nubia; Moreno Sarmiento, Nubia Carmenza; Moreno, Nubia; Piñeros Castro, Nubia Yineth; Medina, Oscar E.; Vargas, Oscar; Moreno-Yañez, Paalo; Torres Estrada, Pablo Alejandro; Acevedo, Paola; Agudelo, Paola; Acevedo Pabón, Paola Andrea; Ortega Guerrero, Paola Andrea; Navarro, Paola; Cuello-Peñaloza, Paolo; Castillo Moreno, Patricia; del Portillo, Patricia; Palmay Paredes, Paul; Junieles-Galán, Paula A.; Rivera León, Paula Andrea; Manrique, Paula; Vargas Molina, Paula Mariana; Olivos, Paula; Rodríguez, Paula; Da Silva, Paulo; Pérez, Jessica G.; Balbuena, Perla B.; Rodríguez, Ramiro; Solano, Ricardo; Jimenez, Rodrigo; Ortega-Toro, Rodrigo; Valderrama, Rodrigo; Vásquez Novoa, Rodrigo; Lizcano Adriana, Rodríguez; Catalina, Rodríguez López; Lagares, Roiver; Acosta, Rolando; Acosta-Fernández, Rolando; Barrera-Zapata, Rolando; Morales, Romel; Mercado, Ronald; Tejada Tovar, Ronald; Carreño, Ruben; Godoy Silva, Rubén Darío; Cardona, Sabrina; Arévalo-Alquichire, Said; Salazar G., Luisa V.; Causil Durango, Saleth; Méramo-Hurtado, Samir; Janeth, Sanabria; Argüello, Sandra; Arroyave, Sandra; Vega Pabón, Sandra Patricia; Rodríguez, Sandra; Céspedes, Santiago; Estevez-Areco, Santiago; Pulgarín-Penagos, Santiago; Sánchez Castañeda, Santiago; Segura Pacheco, Santiago; Torres, Santiago; Valderrama Álvarez, Sara Milena; Venâncio Vianna, Savio Souza; Buitrago, Sebastián; Camacho, Sebastián; Jiménez, Sebastián; Murillo, Sebastián; Cáceres-Roa, Sergio Alejandro; Rozo Perdomo, Sergio Enrique; Duarte Chávez, Shirley Johanna; Sierra P., María A; Goyanes, Silvia; Ochoa, Silvia; Restrepo, Silvia; Mejía, Sol M.; Arias Agudelo, Stefany; Arteaga, Steffy; Franco Ramírez, Sthefania; Huertas Cárdenas, Stiven; Andrés, Suarez; Alejandra, Suarez-Arnedo; Herrera, Tamy; Martha, Tarazona; Ferreira, Tatiele Dalfior; Herrera-García, Udualdo; Urbina Suárez, Néstor Andrés; Méndez, Valentina; Lidueñez Ballesteros, Valentina Sophia; Parejo, Vianny; Baldovino-Medrano, Víctor G.; Gelvez, Víctor; Marulanda, Víctor; Cárdenas Concha, Viktor Oswaldo; Quintero Dallos, Viviana; Sánchez, Viviana; Sánchez Torres, Viviana; Silva, Wilber; Pérez Cabrera, William Alfredo; Aparicio Bayona, William Yamid; Alcaraz, Wilman; Maldonado, Wilson; Oviedo, Xilena; Moya, Xiomara; Muñoz-Muñoz, Y. Mauricio; Peralta-Ruiz, Yeimmy; Morales Cortés, Yenny P.; Yepes Aguilar, Laura Vanessa; Solórzano Fernández, Yerson Arles; Zambrano Salgado, Yesid; Ríos Ramírez, Yesmit Karina; Piñeros-Castro, Yineth; Hernández Berrío, Yomaris; Caballero, Y. T.; Torres, Yusleivis
Academic Journal
Acea-Nebril B; Unidad de Mama. Servicio de Cirugía General, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña, 15004, A Coruña, Spain.; Cereijo-Garea C; Unidad de Mama. Servicio de Cirugía General, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña, 15004, A Coruña, Spain.; García-Novoa A; Unidad de Mama. Servicio de Cirugía General, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña, 15004, A Coruña, Spain.; Varela-Lamas C; Unidad de Mama. Servicio de Cirugía General, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña, 15004, A Coruña, Spain.; Builes-Ramírez S; Unidad de Mama. Servicio de Cirugía General, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña, 15004, A Coruña, Spain.; Bouzón-Alejandro A; Unidad de Mama. Servicio de Cirugía General, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña, 15004, A Coruña, Spain.; Mosquera-Oses J; Unidad de Mama. Servicio de Cirugía General, Instituto de Investigación Biomédica A Coruña (INIBIC), Complejo Hospitalario Universitario A Coruña, 15004, A Coruña, Spain.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE
Academic Journal
Acta Agronomica. July-Sep, 2018, Vol. 67 Issue 3, p402, 12 p.
Academic Journal
García-Novoa A; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España. Electronic address: mag_1406@hotmail.com.; Acea-Nebril B; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Casal-Beloy I; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Bouzón-Alejandro A; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Cereijo Garea C; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Gómez-Dovigo A; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Builes-Ramírez S; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Santiago P; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Mosquera-Oses J; Unidad de Mama, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.
Publisher: Elsevier España Country of Publication: Spain NLM ID: 101771152 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5077 (Electronic) Linking ISSN: 21735077 NLM ISO Abbreviation: Cir Esp (Engl Ed) Subsets: MEDLINE
Academic Journal
In: Journal of Gastrointestinal Surgery . (Journal of Gastrointestinal Surgery, 1 November 2019, 23(11):2312-2313)
Academic Journal
Acea-Nebril, B.; García-Novoa, A.; Cereijo-Garea, C.; Builes-Ramirez, S.; Bouzon-Alejandro, A.; Mosquera-Oses, J.
In: Annals of Surgical Oncology . (Annals of Surgical Oncology, 15 August 2019, 26(8):2466-2474)
Academic Journal
In: Cirugia Espanola . (Cirugia Espanola, August - September 2019, 97(7):409)
Academic Journal
Cereijo-Garea, C.; Rey-Villar, R.; Pita-Fernández, S.; Seoane-Pillado, T.; Balboa-Barreiro, V.; Acea-Nebril, B.; García-Novoa, A.; Varela-Lamas, C.; Builes-Ramirez, S.
In: Journal of Clinical Nursing . (Journal of Clinical Nursing, April 2018, 27(7-8):1464-1474)
Report
García Novoa A; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, La Coruña, España. Electronic address: mag_1406@hotmail.com.; Fernández Soria N; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, La Coruña, España.; Builes Ramírez S; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, La Coruña, España.; Sanluis Verdes N; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, La Coruña, España.; Gómez Gutiérrez M; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, La Coruña, España.
Publisher: Elsevier España Country of Publication: Spain NLM ID: 1254104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-147X (Electronic) Linking ISSN: 0009739X NLM ISO Abbreviation: Cir Esp Subsets: MEDLINE
Editorial & Opinion
Mena Del Río E; Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario A Coruña, A Coruña, España.; Builes Ramírez S; Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario A Coruña, A Coruña, España. Electronic address: Builes_sergio@hotmail.com.; Civeira Taboada T; Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario A Coruña, A Coruña, España.; Mosquera Fernández C; Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario A Coruña, A Coruña, España.
Publisher: Elsevier España Country of Publication: Spain NLM ID: 1254104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-147X (Electronic) Linking ISSN: 0009739X NLM ISO Abbreviation: Cir Esp Subsets: MEDLINE
Editorial & Opinion
Builes Ramírez S; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; García Novoa MA; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, A Coruña, España. Electronic address: mag_1406@hotmail.com.; Fernández Soria N; Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.; Gómez Gutiérrez M; Sección de Hepatobiliopancreática, Servicio de Cirugía General y del Aparato Digestivo, Complejo Hospitalario Universitario de A Coruña, A Coruña, España.
Publisher: Elsevier España Country of Publication: Spain NLM ID: 1254104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-147X (Electronic) Linking ISSN: 0009739X NLM ISO Abbreviation: Cir Esp Subsets: MEDLINE
Academic Journal
Marino, M. V.; Builes Ramirez, S.; Cristobal Poch, L.; Cagigas Fernandez, C.; Gomez Ruiz, M.; Castillo Diego, J.
검색 결과 제한하기
제한된 항목
[검색어] Builes Ramírez, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어